In brief. by Pike, Brigid
 > 2011 report on the drugs 
situation in Europe
 > What are the Ministers 
priorities?
 > Trends in treated 
problem alcohol use
 > National Drugs 
Conference of Ireland
 > Results from the third 
general population 
survey
 > New drink driving limits 
and penalties
 > ACAMH youth mental 
health conference
 > Report of seminar on 
parental substance 
misuse
 > Prioritising children in 
drug policy and practice
 > Quantitative evidence of 
a heroin drought
 > The national community 
detoxiﬁ cation initiative
To have Drugnet Ireland 
delivered to your desktop, 
sign up on the NDC website
www.drugsandalcohol.ie
Drugnet Ireland 
10 years on: what 
have we learned?
See page 12
The value of education in drug 
rehabilitation: report of new 
research
Councillor Emer Costello (former Lord Mayor 
of Dublin) launched a research report in 
October 2011 on the role and beneﬁ ts of 
education in drug rehabilitation and recovery 
from addiction.1 The report is derived from 
an analysis of data from in-depth interviews 
with 20 individuals in recovery from 
substance addiction.
 All of the people interviewed had progressed 
through the Health Service Executive (HSE) 
Soilse drug rehabilitation programme. The 
data were analysed using the recovery 
capital framework, which looks at social, 
physical, human and cultural outcomes. 
The framework was initially developed by 
Granﬁ eld and Cloud in 19992 in their study 
of 46 individuals who overcame substance 
dependence without the aid of formal 
treatment or recourse to self-help groups, 
and reﬁ ned by the same authors in 2008.3 
The present study with former participants in 
the Soilse programme was the ﬁ rst attempt 
to apply the construct of recovery capital to 
addiction recovery in Ireland. 
Most of the interviewees were early school 
leavers, with modest formal educational 
achievements, little in the way of sustained 
employment and a history of having 
experienced conﬂ ict in the home. Since 
becoming involved in adult education 
through Soilse, most had achieved third-level 
degrees or diplomas.
According to Cloud and Granﬁ eld,3 recovery 
capital is the sum of resources necessary to 
initiate and sustain recovery from substance 
misuse. The authors identify four dimensions 
to recovery capital:
Social capital – the sum of resources 
that each person has as a result of their 
relationships, support from and obligations 
to groups to which they belong. 
Physical capital – tangible assets such as 
property and money that may increase 
recovery options. 
Human capital – personal skills and 
education, positive health, aspirations and 
hopes; key aspects of human capital, and will 
At the launch of the report: Gerry McAleenan of Soilse, Prof Joe Barry of TCD, and author 
of the report Martin Keane of the HRB  (Photo: JJ Berkeley)
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help with some of the problem solving that is 
required on a recovery journey.
Cultural capital – values, beliefs and attitudes 
that link the individual to social attachment and 
the ability to ﬁ t into dominant social behaviour.
Study ﬁ ndings
This study of 20 people in self-reported recovery 
from substance addiction demonstrated the 
contribution that education can make to 
developing recovery capital. Education played a 
role in all four dimensions for the participants in 
this study: it improved social capital by opening 
up opportunities to develop new networks of 
friends outside the conﬁ nes of formal treatment 
and self-help groups; it improved physical 
capital by improving career options and 
job opportunities, which can improve living 
standards; and it improved cultural capital by 
exposing people to new values, beliefs and 
attitudes and instilling a revised work ethic 
grounded in the demands of educational 
pursuits. Finally, education contributed to 
recovery capital by improving human capital, 
empowering these people to look after their 
health, become more effective parents, 
reappraise ingrained negative belief systems, 
develop achievable goals and improve day-to-
day functioning and personal efﬁ cacy. 
Ofﬁ cial treatment programmes can play a 
vital role in halting addiction and promoting 
recovery and can beneﬁ t people on a number 
of therapeutic levels. However, when people 
emerge from treatment they need to transfer 
these beneﬁ ts into day-to-day living and also 
navigate their way into and through real-life 
situations. Returning to adult education can 
enable people in recovery to build sufﬁ cient 
recovery capital to assist them on this journey 
and help them to reproduce their recovery on a 
day-to-day basis. Drug policy and practice can 
be strengthened by giving renewed emphasis 
to the role of education in developing recovery 
capital. Finally, engaging with adult education 
while in recovery can open up opportunities 
for people that can provide them with rewards 
which they will not risk losing, such as legitimate 
income, sustainable housing, improved relations 
with family and a sense that they belong 
to a community. The importance of these 
components of sustained recovery is neatly 
encapsulated by Neale.4 
Recovery will only occur if drug users believe 
that abstinence has more to offer than 
addiction. Accordingly, recovering drug 
users must ﬁ nd a purpose for their drug-free 
lives. To this end, they need meaningful 
roles and activities that offer them self-
respect and pride, and daily routines that 
do not involve criminal or drug-using 
activities. …the conditions that seem likely 
to facilitate successful rehabilitation are 
the same kinds of conditions that probably 
prevent drug misuse in the ﬁ rst place. That 
is, access to a decent income; adequate 
housing; employment opportunities; 
family relationships; and being connected 
to community networks. …these are also 
key factors motivating most non-addicted 
members of society... (pp. 218–219)
(Martin Keane)
1. Keane M (2011) The role of education in 
developing recovery capital in recovery from 
substance addiction. Dublin: Soilse Drug 
Rehabilitation Project.
2. Granﬁ eld R and Cloud W (1999) Coming 
clean: overcoming addiction without 
treatment. New York: New York University 
Press. 
3. Cloud W and Granﬁ eld R (2008) 
Conceptualising recovery capital: expansion 
of a theoretical construct. Substance Use and 
Misuse, 43 (12–13): 1971–1986
4. Neale J (2002) Drug users in society. 
Basingstoke: Palgrave Macmillan.
The value of education in drug rehabilitation (continued)
Trends in treated problem 
alcohol use 
A recent addition to the HRB Trends Series, Treated problem alcohol use in Ireland 2005 to 2010,1 
was published in November 2011. Number 11 in the series, the paper is based on data reported to 
the National Drug Treatment Reporting System (NDTRS). It is important to note that the reporting 
system collects data on episodes of treatment, rather than the number of individual people treated 
each year. This means that individuals may appear more than once if they attend more than one 
treatment service in a year, and may reappear in subsequent years. The main ﬁ ndings of the paper are 
summarised below. 
Numbers treated
In the period 2005–2010, a total of 42,333 cases presented with alcohol as a main problem 
substance, accounting for more than half (52.7%) of all cases treated for problem substance use 
during that period. 
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3The incidence of such cases increased from 109.9 per 
100,000 of the 15–64-year-old population in 2005 to 133.2 
per 100,000 in 2010. The prevalence increased from 187.6 
per 100,000 in 2005 to 251.6 per 100,000 in 2010. This 
is an indication that problem alcohol use is a recurring 
addiction that requires repeated treatment over time. 
These increases in incidence and prevalence may be 
explained by a true increase in problem alcohol use in the 
population, an increase in reporting to the NDTRS, or a 
combination of both.
Figure 1 Incidence and prevalence of cases per 100,000 of the 15–64-year-old population (NDTRS 2005–2010) 
 The incidence of cases treated for alcohol as a main problem 
drug was analysed by county for two distinct time periods: 
2005–2007 and 2008–2010. In the period 2005–2007 
the incidence rates per 100,000 of the 15–64-year-
old population were highest in Sligo, Donegal, Leitrim, 
Waterford, Cavan and Wexford (with more than 200 
cases per 100,000), and lowest in Mayo, Roscommon and 
Galway. The rates were also low in Dublin and Wicklow 
(with less than 100 cases per 100,000). These low rates may 
be explained by low levels of participation in the NDTRS 
by services in these counties prior to 2007. In the period 
2008–2010 the incidence rates were highest in Waterford, 
Leitrim and Donegal and lowest in Wicklow, Clare and Laois. 
The annual number of cases increased from 5,525 in 2005 to 
7,866 in 2010. This increase reﬂ ects the growing number of 
treatment centres participating in the NDTRS, but may also 
point to an increase in the number of people presenting for 
treatment. 
The number of new cases rose by 29.4%, from 3,228 in 
2005 to 4,178 in 2010. The number of previously treated 
cases also increased (by 60.7%), from 2,229 in 2005 to 
3,583 in 2009. 
The largest proportion (39.4%) of cases in 2010 lived in the 
HSE South Region, and more than one quarter (25.6%) lived 
in the HSE West Region. 
Table 1 Number (%) of cases treated, by treatment status (NDTRS 2005–2010)
Treatment 
status
2005 2006 2007 2008 2009 2010
n (%) n (%) n (%) n (%) n (%) n (%)
All cases 5525 5874 7312 7940 7816 7866
New cases 3228 (58.4) 3431 (58.4) 3736 (51.1) 3833 (48.3) 4220 (54.0) 4178 (53.1)
Previously 
treated cases 2229 (40.3) 2344 (39.9) 3110 (42.5) 3606 (45.4) 3524 (45.1) 3583 (45.6)
Treatment status 
unknown 68 (1.2) 99 (1.7) 466 (6.4) 501 (6.3) 72 (0.9) 105 (1.3)
Substances used in conjunction with alcohol 
Almost one in ﬁ ve of those treated for alcohol as a main 
problem substance also reported using at least one 
other substance. In 2010, the most common drugs used 
in conjunction with alcohol were cannabis, cocaine, 
benzodiazepines and ecstasy. This reﬂ ects a minor change 
since 2008, when opiates were the fourth most common 
additional drug. Use of more than one substance increases 
the complexity of cases and leads to poorer outcomes for 
the patient. Information about combinations of substances 
used is important in terms of individual clients’ care plans. 
Trends in treated alcohol use (continued)
 2005 2006 2007 2008 2009 2010
Incidence (new cases) 109.9 113.4 121.0 122.0 134.1 133.2
Prevalence (all cases) 187.6 194.1 237.1 253.1 248.7 251.6
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4 2005 2006 2007 2008 2009 2010
Cannabis 895 839 976 1016 961 937
Cocaine 384 360 538 601 476 426
Ecstasy 400 334 400 418 261 229
Benzodiazepines 99 106 148 179 193 231
Opiates 90 88 129 182 140 145
Amphetamines 109 116 94 94 60 73
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Figure 2 All cases: additional problem substances associated with alcohol as a main problem substance (NDTRS 
2005–2010) 
Daily
2–6 times per week
Once a week or less
No use in the last month
Not known
39.9%
34.1%
13.9%
8.0%
4.1%
Figure 3 Frequency of alcohol use in the month prior to treatment (NDTRS 2005–2010)
Patterns of alcohol use
The largest percentage (39.9%) of cases in the period 
2005–2010 reported using alcohol daily (Figure 3). 
In 2010, 31.0% used alcohol daily, 38.1% used it between 
two and six days per week, 9.0% used it once per week 
or less, and 17.5% had not used it in the month prior to 
entering treatment. In the same year, the ﬁ gure for ‘daily 
use’ was higher for previously treated cases (33.2%) than for 
new cases (29.4%).
Half of all cases had begun drinking by the age of 16 
years. This was true for new and previously treated cases. 
Of those who reported ever using drugs (10,336, 25.4%), 
the median age at which they commenced the illicit use 
of drugs remained constant over the reporting period. By 
the time they were 16 years old, half of all those treated for 
problem alcohol use had commenced the illicit use of drugs 
(excluding alcohol and tobacco). 
Trends in treated alcohol use (continued)
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was 36 years. Half of the new alcohol cases had used alcohol 
for 19 years or more before seeking treatment.
Socio-demographic characteristics 
Half of those treated for alcohol as a main problem 
substance were aged 40 years or under. The age proﬁ le of 
cases remained similar throughout the reporting period. The 
median age for all treated cases was 39 years; the median 
age for new cases continued to be lower (36 years). While 
the proportion of cases aged under 18 years remained small, 
the number of new cases in that age group rose by 151.9% 
in the reporting period. 
The socio-demographic characteristics of cases, both 
new and previously-treated, remained similar throughout 
the reporting period. The majority of cases were male, 
with low levels of employment. The proportion of cases 
in employment fell in the years 2008 to 2010, possibly 
reﬂ ecting the current economic climate. The proportion of 
cases who were homeless fell slightly between 2008 and 
2009, but rose again in 2010: new cases from 2.4% to 1.5% 
to 2.3%, and previously-treated cases from 6.9% to 5.0% to 
6.5%. Those who used other substances as well as alcohol 
were more likely to be unemployed and to live in unstable 
accommodation. 
The ﬁ ndings and their implications are presented in detail in 
the Trends Series paper. An online Appendix to the paper, 
containing additional tables and ﬁ gures with supplementary 
data, is available at www.drugsandalcohol.ie/16037
(Anne Marie Carew)
1. Carew AM, Bellerose D and Lyons S (2011) Trends in 
treated problem alcohol use in Ireland 2005 to 2010. HRB 
Trends Series 11. Dublin: Health Research Board. www.
drugsandalcohol.ie/16037
Trends in treated alcohol use (continued)
2011 report on the drugs situation in 
Europe
The annual report for 20111 from the European Monitoring 
Centre for Drugs and Drug Addiction (EMCDDA) was 
published on 15 November. The Health Research Board 
(HRB) provides the Irish ﬁ gures for the EMCDDA report. 
The report shows drug use to be relatively stable in Europe, 
with some positive signs that cocaine use may have peaked 
and that cannabis use continues to decline among young 
people in many countries. The number of new cases 
entering treatment for problem cocaine use has declined 
over the past two years, indicating a possible decrease in 
cocaine use in Ireland. The 2007 Health Behaviour in School-
aged Children (HBSC) survey shows a small increase in 
lifetime cannabis use among schoolchildren over three time 
points, indicating that cannabis use continues to increase 
among young people in Ireland. 
Signs of stability in relation to some of the more established 
drugs are offset by new threats across Europe. Over the last 
nine years, and more intensively over the last three to four 
years, the selling of new psychoactive substances in head 
shops and online has emerged as a new phenomenon across 
Europe, including Ireland.
Opiates (mainly heroin)
Around 5% of those entering treatment for drug problems 
now report opiates other than heroin as their primary 
drug; this proportion is much higher in Northern Europe. 
For instance, three quarters of those entering treatment 
in Estonia now report fentanyl, a synthetic opiate, as their 
main problem drug. In Ireland around 2% of those entering 
treatment for drug problems reported opiates other than 
heroin as their primary drug.
Among opiate users entering treatment, rates of injecting 
vary considerably between countries, ranging from under 
10% in the Netherlands to over 90% in Latvia and Lithuania. 
However, a ﬁ ve-year analysis of trends among heroin users 
entering treatment shows that the proportion of those 
reporting injecting (40% in 2009) is falling in most European 
countries. In Ireland 36% of heroin users entering treatment 
reported injecting drug use. The proportion of injector cases 
has decreased since 2005. The EMCDDA estimates that 
between 10,000 and 20,000 opiate users die each year from 
overdose, disease, suicide and trauma. The report estimates 
that the mortality rate among regular opiate users is 10 to 
20 times higher than that among their non-opiate-using 
peers. Opiates continued to be associated with the majority 
of fatal overdoses in Ireland. In 2009, 180 poisoning deaths 
were associated with opiates, alone or with another drug. A 
total of 1,345 non-poisoning deaths were recorded among 
drug users between 1998 and 2007; 60% were due to 
trauma (mainly hangings and road trafﬁ c collisions) and 
40% were due to medical causes (mainly cardiac events and 
respiratory infections). The proportion attributable to opiate 
use has not been calculated.
The availability of heroin was reported to have dropped in 
a number of European countries at the end of 2010 and in 
early 2011, with the drought being particularly evident in 
the UK and Ireland. (See Quantitative evidence of a heroin 
drought on page 21 of this issue.)
Cocaine
Of the ﬁ ve high-prevalence countries, four – Denmark, 
Spain, Italy and the UK – reported a decline in last-year 
cocaine use among young adults. Ireland is ranked ﬁ fth 
for cocaine use in the EU. The 2010/11 NACD general 
population survey2 reported that 1.5% of adults had 
used cocaine in the year prior to the survey and that the 
percentage was higher among young adults (2.8%) and 
among men (2.3%). Around 17% of drugs users entering 
treatment reported cocaine as their main problem drug . 
In Ireland in 2009, 11% of those who entered treatment 
reported cocaine as their primary drug; this proportion fell 
to 9% in 2010.
Cannabis
Cannabis is still Europe’s most commonly consumed illicit 
drug. One in ﬁ ve adults aged 15–64 years have tried 
cannabis at some point in their lives. The latest European 
data conﬁ rm the general stabilisation or downward trend in 
cannabis use among young adults (15–34 years). Surveys of 
school children mirror this decline. Ireland is placed in the 
mid-range for cannabis use. The 2010/11 NACD general 
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population had used cannabis in the year prior to the survey. 
The number of cannabis users attending treatment increased 
from 991 in 2003 to 1,893 in 2010, when it represented 
25% of all clients in treatment. 
New psychoactive substances
The European Early Warning System identiﬁ ed 24 new 
psychoactive substances in 2009, 41 in 2010 and 34 in 
2011. The most recent EMCDDA snapshot survey of online 
retailers selling new psychoactive substances identiﬁ ed over 
600 online shops, almost twice as many as a year ago. The 
survey also revealed a variety of new products, an increase 
in warnings, restrictions and disclaimers. It also revealed an 
increasing ability to mask the identities of both sellers and 
buyers. Ireland has had notable success in limiting the sale of 
new psychoactive substances. This was achieved through the 
combined efforts of a number of government departments 
and statutory agencies. 
(Brian Galvin)
1. EMCCDA (2011) Annual report 2011: the state of the 
drugs problem in Europe. Luxembourg. Publications Ofﬁ ce 
of the European Union. www.drugsandalcohol.ie/16288 
2. National Advisory Committee on Drugs. (2011) 
Drug use in Ireland and Northern Ireland: ﬁ rst results 
from the 2010/2011 drug prevalence survey. Dublin. 
National Advisory Committee on Drugs & Public 
Health Information and Research Branch. www.
drugsandalcohol.ie/16353
2011 report on the drugs situation in Europe (continued)
Results from the third general 
population survey in Ireland 
On 22 November 2011, the National Advisory Committee 
on Drugs (NACD) and and the Public Health Information 
and Research Branch (PHI RB) of the Department of Health, 
Social Services and Public Safety (DHSSPS) in Northern 
Ireland published jointly the results of the third all-Ireland 
general population drug prevalence survey.1 These surveys 
are done every four years. This article presents a summary of 
the methods and results for Ireland. 
The 2010/11 survey followed best practice guidelines 
recommended by the European Monitoring Centre for Drugs 
and Drug Addiction (EMCDDA). The questionnaire, based 
on the European Model Questionnaire, was administered in 
face-to-face interviews with respondents aged between 15 
and 64 years normally resident in households in Ireland. The 
questionnaire had been revised to include better measures of 
problematic alcohol and cannabis use, and three questions 
about new psychoactive substances sold in head shops or 
online. The detailed results from these new questions will 
be published in future bulletins. The response options for 
questions about other opiate-type substances used were 
increased to include codeine and other commonly used 
opiates; this may account for the increase in the use of other 
opiates when compared to the previous surveys. Fieldwork 
was carried out by MORI MRC during late 2010 and early 
2011. Of the household members contacted, 5,134 (60%) 
agreed to take part. The sample was weighted by gender, 
age and region to ensure that it was representative of the 
general population. The main measures of use were lifetime 
(ever used), use in the last year (recent use) and use in the 
last month (current use). 
Use of any illegal drug
Compared with the previous survey, the proportion of adults 
(aged 15–64 years) who reported using an illegal drug in 
their lifetime increased by just over 3%, from 24% in 2006/7 
to 27.2% in 2010/11 (Table 1). The proportion of young 
adults (aged 15–34 years) who reported using an illegal 
drug in their lifetime also increased, by just over 4%, from 
31.4% in 2006/7 to 35.7% in 2010/11. As expected, more 
men (35.5%) reported using an illegal drug in their lifetime 
than women (19%). 
The proportion of adults who reported using an illegal 
drug in the last year remained reasonably stable at 7.2% 
in 2006/7 and 7% in 2010/11 (Table 1). The proportion of 
young adults who reported using an illegal drug in the last 
year also remained stable, at 12.2% in 2006/7 and 12.3% 
in 2010/11. The proportion of young adults who reported 
using an illegal drug in the last month was 5.3%. 
Table 1 Lifetime, last-year and last-month prevalence of illegal drug use in Ireland, 2002/3, 2006/7 and 2010/11
Illegal 
drug 
use*
Adults 
15–64 years
%
Males 
15–64 years
%
Females 
15–64 years
%
Young adults 
15–34 years
%
2002/3 2006/7 2010/11 2002/3 2006/7 2010/11 2002/3 2006/7 2010/11 2002/3 2006/7 2010/11
Lifetime 18.5 24.0 27.2 23.8 29.5 35.5 13.1 18.6 19.0 25.9 31.4 35.7
Last 
year 5.6 7.2 7.0 7.8 9.8 10.4 3.4 4.7 3.6 9.8 12.2 12.3
Last 
month 3.0 2.9 3.2 4.1 4.5 5.3 1.8 1.4 1.1 5.2 5.0 5.3
*Amphetamines, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents.
Source: National Advisory Committee on Drugs (NACD) & Public Health Information and Research Branch (PHIRB) (2011)
Cannabis use
Lifetime cannabis use increased over the four years since 
the 2006/7 survey, but last-year use remained stable (Table 
2). The proportion of adults who reported using cannabis 
at some point in their life increased from 21.9% in 2006/7 
to 25.3% in 2010/11. The proportion of young adults who 
reported using cannabis in their lifetime also increased, 
from 28.6% in 2006/7 to 33.4% in 2010/11. The lifetime 
prevalence rate in 2010/11 was higher for men (33.2%) 
than for women (17.5%).
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last year did not decrease signiﬁ cantly in 2010/11 (6.0%) 
when compared to 2006/7 (6.3%). The proportion of young 
adults who reported using cannabis in the last year remained 
reasonably stable over the last two survey periods (Table 2). 
The proportion of adults who reported using cannabis in the 
last month remained stable also, at 2.8%.
Table 2 Lifetime, last-year and last-month prevalence of cannabis use in Ireland, 2002/3, 2006/7 and 2010/11
Cannabis 
use
Adults 
15–64 years
%
Males 
15–64 years
%
Females 
15–64 years
%
Young adults 
15–34 years
%
2002/3 2006/7 2010/11 2002/3 2006/7 2010/11 2002/3 2006/7 2010/11 2002/3 2006/7 2010/11
Lifetime 17.3 21.9 25.3 22.2 27.2 33.2 12.3 16.8 17.5 23.8 28.6 33.4
Last year 5.1 6.3 6.0 7.2 8.8 9.1 2.9 3.9 2.9 8.6 10.6 10.3
Last 
month 2.6 2.6 2.8 3.4 4.1 4.7 1.7 1.2 0.9 4.3 4.3 4.5
Source: National Advisory Committee on Drugs (NACD) & Public Health Information and Research Branch (PHIRB) (2011)
Cocaine use
Lifetime cocaine use increased in 2010/11 compared to 
2006/7, but last-year use remained stable. The proportion of 
adults who reported using cocaine (including crack) at some 
point in their lives increased from 5.3% in 2006/7 to 6.8% 
in 2010/11 (Table 3). The proportion of young adults who 
reported using cocaine in their lifetime also increased, from 
8.2% in 2006/7 to 9.4% in 2010/11. More men (9.9%) 
reported using cocaine in their lifetime than women (3.8%). 
The proportion of adults who reported using cocaine in 
the last year remained reasonably stable at 1.7% in 2006/7 
and 1.5% in 2010/11 (Table 2.2.3). The proportion of 
young adults who reported using cocaine in the last year 
did not vary signiﬁ cantly, being 3.1% in 2006/7 and 2.8% 
in 2010/11. The proportion of adults who reported using 
cocaine in the last month remained stable at 0.5%.
Table 3 Lifetime, last-year and last-month prevalence of cocaine use (including crack) in Ireland, 2002/3, 2006/7 and 
2010/11
Cocaine 
use
Adults 
15–64 years
%
Males 
15–64 years
%
Females 
15–64 years
%
Young adults 
15–34 years
%
2002/3 2006/7 2010/11 2002/3 2006/7 2010/11 2002/3 2006/7 2010/11 2002/3 2006/7 2010/11
Lifetime 3.0 5.3 6.8 4.3 7.1 9.9 1.6 3.5 3.8 4.7 8.2 9.4
Last 
year 1.1 1.7 1.5 1.7 2.3 2.3 0.5 1.0 0.7 2.0 3.1 2.8
Last 
month 0.4 0.5 0.5 0.7 0.8 0.8 0.0 0.2 0.3 0.7 1.1 1.0
Source: National Advisory Committee on Drugs (NACD) & Public Health Information and Research Branch (PHIRB) (2011)
Ecstasy use
Almost 11% of young adults surveyed in 2010/11 claimed 
to have tried ecstasy at least once in their lifetime (Table 
4). More young men (15%) reported using ecstasy in 
their lifetime than young women (6%). The proportion of 
young adults who used ecstasy in the last year decreased 
signiﬁ cantly, from 2.4% in 2006/7 to 0.9% in 2010/11. 
The decrease in ecstasy use may be partly explained by the 
proportion (6.7%) of young people reporting use of new 
psychoactive substances sold in head shops and on line. 
Table 4 Lifetime, last-year and last-month prevalence of ecstasy use in Ireland, 2002/3, 2006/7 and 2010/11
Ecstasy 
use
Adults 
15–64 years
%
Males 
15–64 years
%
Females 
15–64 years
%
Young adults 
15–34 years
%
2002/3 2006/7 2010/11 2002/3 2006/7 2010/11 2002/3 2006/7 2010/11 2002/3 2006/7 2010/11
Lifetime 3.7 5.5 6.9 4.9 7.4 10.1 2.6 3.6 3.7 7.1 9.1 10.9
Last 
year 1.1 1.2 0.5 1.5 1.8 0.6 0.6 0.6 0.3 2.3 2.4 0.9
Last 
month 0.3 0.3 0.1 0.6 0.5 0.1 0.0 0.2 0.0 0.6 0.6 0.1
Source: National Advisory Committee on Drugs (NACD) & Public Health Information and Research Branch (PHIRB) (2011)
The increase in the proportions using any illegal drug at 
some point in their lives between 2006/7 and 2011/12 was 
inﬂ uenced by the fact that drug use in Ireland is a recent 
phenomenon and the population of lifetime and recent drug 
users is relatively young. Drug use is measured among adults 
aged 15–64, and those leaving this age group over the next 
ﬁ ve years are less likely to have been exposed to drug use 
than those entering the measurement cohort. The relative 
stability in last-year use of cannabis and cocaine indicates 
that the situation with respect to these drugs has stabilised. 
When compared to the 19 other countries that completed a 
general population survey on drug use using the European 
Results from the third general population survey (continued)
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use of cannabis, fourth for lifetime use of amphetamines, 
fourth for use of cocaine, second for ecstasy and second 
for LSD.2
(Jean Long)
1. National Advisory Committee on Drugs (NACD) & Public 
Health Information and Research Branch (PHIRB) (2011) 
Drug use in Ireland and Northern Ireland: ﬁ rst results from 
the 2010/11Drug Prevalence Survey. Bulletin 1. Dublin: 
NACD & PHIRB. www.drugsandalcohol.ie/16450
2. European Monitoring Centre for Drugs and Drug 
Addiction (2011) Statistical bulletin 2011. Accessed 20 
November 2011 at www.emcdda.europa.eu/stats11/gps 
Results from the third general population survey (continued)
National Drugs Conference of Ireland 
2011
The second National Drugs Conference of Ireland took place 
at the Radisson Blu Hotel in Dublin 8 on 3–4 November 
2011. The theme of the conference was ‘Drug Interventions: 
what works?’ The packed, two-day programme brought 
together a wide range of people from the community/
voluntary sector as well as from government organisations to 
share knowledge, expertise and good practice in drug policy 
and drug service provision in Ireland. Some 275 delegates 
were in attendance.
Opening the conference, Minister of State Róisín Shortall 
stressed that all drug interventions should have a strong 
evidence base. She warned that resources would remain 
tight and that ‘we must ensure the limited public funding 
that is available is used in the most effective and optimum 
way’. She said that agencies should work together and 
play a part in implementing the National Substance Misuse 
Strategy.
Ms Shortall said the response to drug addiction needed to 
be client-centred and should ultimately enable service users 
to address their health, social, housing and employment 
needs. She pointed to family involvement as an important 
tool in ﬁ ghting addiction, saying it increased the likelihood 
of successful outcomes and decreased the chances of 
relapse. Ms Shortall stated that she would like to see clients 
move more quickly through methadone programmes and 
into recovery. She said she was looking for information from 
the HSE on the length of time people were in methadone 
treatment and that she wanted more GPs involved in 
treatment. She also stated that she was pleased to have 
signed an order classifying 60 psychoactive substances sold 
in head shops as controlled substances. 
Referring to alcohol, the minister said that alcohol has 
become ‘dirt cheap’ and that, in many cases, young people 
were not able to handle the amount of alcohol they could 
now afford. She spoke of the need to reduce alcohol 
consumption and said that the Governement will examine 
recommendations on pricing and availability including 
minimum pricing.
Over the two days there were 19 Irish and international 
plenary speakers, as well as 26 speakers across parallel 
sessions. This article can give only a brief overview of the 
proceedings. Further information and a number of the 
presentations can be accessed at www.inef.ie. 
Various organisations and researchers took the opportunity 
of launching/presenting their recent work at the conference. 
Siobhan Cafferty from Pavee Point launched Good practice 
guidelines for drug and alcohol services for Travellers, which 
can be accessed at www.drugsandalcohol.ie/16232. Marie 
Claire van Hout and Tim Bingham launched Holding 
pattern: an exploratory study of the lived experiences of those 
on methadone maintenance in Dublin North East, which can 
be accessed at www.drugsandalcohol.ie/16250. Robert 
O’Driscoll and Miriam Keogh presented their research Inter-
agency practice and outcomes for teenagers with addiction 
and social services. Gary Broderick launched Reduce the 
use 2, a manual for professionals working with polydrug 
users developed by the SAOL Project and available at www.
drugsandalcohol.ie/16230. Aoife Dermody launched 
two protocols on behalf of Progression Routes Initiative 
– Community detoxiﬁ cation protocols: benzodiazepines and 
Community detoxiﬁ cation protocols: methadone. Both of these 
reports are available at www.drugsandalcohol.ie.
Dr Joao Goulao spoke about the impact of drug policies in 
Portugal, in particular, the introduction of policy in 2001 
that led to the decriminalisation of drug use. Under this 
policy, people who are caught in possession of drugs for 
personal use are dealt with by a commission comprising a 
legal expert, a health professional and a social worker. He 
stated that decriminalisation has not had a negative impact 
and that drug addicts are now seen as sick people with 
treatment needs rather than delinquents. 
Dr Paolo Deluca introduced the delegates to the 
Recreational Drugs European Network (ReDNet) project, a 
multi-site implementation project with the aim of improving 
the level of information available to young people (aged 
16–24) and professionals on the effects of new recreational 
drugs and the potential health risks associated with their 
use. This is available at www.rednetproject.eu. On a similar 
topic, Ann Campbell described her research ﬁ ndings on 
adolescents’ experiences of psychoactive substances in 
Ireland. 
Dr Andrew Tatarsky, a plenary speaker at the conference
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participants gave the delegates an enjoyable ten minutes as 
they performed their own drama, Get stoned, which 
challenged the stereotypical views of drug users, law 
enforcement, the community and politicians regarding drug 
use. Martin Woods spoke about the link between drug 
killing in Mexico, money laundering in London and whistle 
blowing. He was followed by Johnny Connolly, who 
described drug markets in Ireland. 
Dr Tom McLellan spoke of the scope of substance use in 
the US, where there are 13,200 treatment programs. He 
queried the current approach to treatment, saying that it 
needs to become more patient-centred and more integrated 
into healthcare. Damon Barrett described drug policy from 
a human rights perspective and said that more work needs 
to be done in this area. Dr Jenny Scott gave an overview of 
the pharmacist’s role within a community pharmacy needle 
exchange in the UK, after which Denis O’Driscoll gave 
the delegates an update on a similar scheme in Ireland. He 
said that 42 pharmacies will be involved in the scheme by 
the end of 2011, with a further 30 becoming involved in 
2012. Marion Rackard outlined the National Rehabilitation 
Framework Training programme, which will involve 10 pilot 
sites, ﬁ ve protocols to establish national standards and three 
key modules.
(Deirdre Mongan and Mairea Nelson)
National Drugs Conference 2011 (continued)
What are the Minister’s priorities?
On 22 September 2011 Róisín Shortall TD, Minister of 
State at the Department of Health with responsibility for 
Primary Care and the Drugs Issue, appeared before the Joint 
Committee on Health and Children to talk about illegal drug 
use. Below are excerpts from the Minister’s responses to the 
Committee.1
 Legal highs
 … work is well advanced in my Department on the 
introduction of regulations under the Misuse of Drugs Acts 
to control a further extensive range of products.
Needle exchange
 Approval has recently been granted for the proposed 
provision of needle exchange services in approximately 
65 community pharmacies at various locations outside 
Dublin, with part funding being provided by the Elton John 
Aids Foundation. A national liaison pharmacist has been 
appointed to oversee this programme, the roll-out of which 
will begin next month. Needle exchange services in Dublin 
are provided through HSE clinics, and through voluntary 
sector providers, so this initiative will facilitate broad national 
coverage.
Methadone treatment
I am concerned about people getting stuck on methadone 
without having an adequate progression through the system 
[to a drug-free life].  … We are examining ways of ensuring 
there is that kind of progression by involving more GPs. I see 
no reason a large number of drug users’ regular GPs cannot 
provide treatment for their drug problem, just as they treat 
them for any other health problem they may have. A certain 
cohort of drug users would be regarded as quite chaotic and 
would not be suitable for treatment in local GPs’ surgeries. 
Many drug users, however, should be treated by GPs and, 
therefore, I want to see those GPs’ services being expanded. 
I am working on that at the moment.
Alcohol
 I hope to bring forward speciﬁ c proposals on three key 
areas of concern, the ﬁ rst of which is pricing. … Personally, 
I would be very committed to going that route [minimum 
pricing] if it were legally sound. That is the basis on which 
we are proceeding to address that problem. …  the other key 
area is the explosion in the number of outlets for alcohol. 
… Alcohol is not a normal product for sale in a supermarket 
like food, milk, minerals or whatever. It is a potentially 
dangerous product and for that reason, it needs to be 
treated differently to other products. It was a retrograde 
step to liberalise the licensing laws in the way we did, which 
opened up the question of availability. …  The other area is 
clearly the availability of alcohol to those under age. ... We 
need to tackle the issue of distance selling  … We also need 
to tackle the question of under age sales and there needs 
to be greater enforcement of the law in that area. …  The 
third area is the question of those over 18 buying alcohol 
for those aged 13 or 14 waiting outside. I am not satisﬁ ed 
that there has been adequate enforcement of the law in that 
area. ... I would like to see us being much more vigorous in 
that regard and there will be proposals on that in the new 
strategy.
Benzodiazepines
 I have decided to take an initiative on the information 
available to us on persons on medical cards who are 
prescribed benzodiazepines as well as persons who avail 
of the community drugs scheme. As the committee will 
be aware, all of those data are available in the primary 
care reimbursement centre in Finglas. There are rich data 
available on exactly what is happening in prescribing for 
most of the population.
 I hope, starting next month, that an in-house team within 
the PCRS will investigate those ﬁ gures, look in detail at 
prescribing patterns in respect of benzodiazepines, and 
identify problem areas, problem practices, problem GPs 
in terms of their prescribing patterns and where patterns 
are out of line with national norms and best international 
practice. At that point, when we have the data to see the 
extent of the problem, we will take it to the next step further 
where that team will meet GPs where there are difﬁ culties, 
address it at that level and work with those GPs to bring 
their prescribing patterns into line with best practice. 
Treatment waiting times
 In the Dublin area, waiting times are approximately one 
month. That is an improvement but a month is still too long. 
… I am aiming for two weeks. … Progress is being made in 
this area. It entails acceptance of new treatment facilities and 
the recruitment of more GPs.
 Education
There are common threads in the proﬁ le of those most at 
risk of using heroin, in particular, such as poverty, family 
dysfunction and early school leaving. All those factors 
predispose people to abusing drugs. Education programmes 
in schools need to tackle the problem of low self-esteem 
and to provide education and employment opportunities for 
people as well as making them aware of the dangers of the 
abuse of alcohol and illicit drugs. Programmes are in place 
in schools and a group within the Department of Education 
and Skills is reviewing them to ensure they are up to date 
and relevant to where young people ﬁ nd themselves.
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Drugs task forces
 I am currently reviewing the role of the drugs task forces in 
respect of accountability and clarity of their role in terms of 
oversight of the projects they sponsor. … We need better 
evaluation to ensure good standards are in place. This will be 
part of the evaluation to be carried out.
 There are real strengths in having this type of local response 
to the drug problem in areas where there is greatest 
prevalence. The local drugs task forces are in the 14 most 
disadvantaged areas, in terms of the greatest use of heroin 
in particular. The local drug task forces provide a local forum 
for the community, voluntary sector, statutory agencies and, 
in many cases, public representatives to work together to 
address the local problem in a meaningful and constructive 
way. I am examining the composition of the drugs task 
forces. I would like to see public representatives playing a 
greater role in the drugs task forces. … 
 There is often confusion between groups working under 
the banner of the drugs task forces and those that are 
community development projects, partnership companies 
and so on. It is important to distinguish between the 
work of the different sectors. There are concerns about 
various aspects of the different schemes. We are currently 
examining those to ensure coherence and a better level 
of accountability in that regard. I would be nervous about 
tarring all community bodies with the same brush. We need 
to acknowledge that there is now greater accountability 
and evaluation in that regard. We must distinguish between 
those that are good and those that could be much better.
(Compiled by Brigid Pike)
1. Róisín Shortall (2011, 22 September) Illegal drug 
use: discussion (resumed). Houses of the Oireachtas: 
Joint Committee on Health and Children. Accessed 
1 December 2011 at http://debates.oireachtas.ie/
HEJ/2011/09/22/
What are the Minister’s priorities (continued)
Drugnet digest
This section contains short summaries of recent reports and 
other developments of interest.
Minister bans more head shop products
On 1 November 2011 Róisín Shortall TD, Minister of 
State with responsibility for drugs strategy, approved an 
Order declaring a further sixty or more new psychoactive 
substances being sold in head shops or online to be 
controlled drugs under the Misuse of Drugs Act 1977. 
These substances include: 
• additional cathinone substances (similar to 
mephedrone, which was controlled in May 2010) 
• naphthylpyrovalerone and related substances (such 
as the product Pure NRG) further synthetic cannabis-
type substances (often sold as smoking mixtures) 
• dimethocaine and desethyl dimethocaine (contained 
in the products Ampliﬁ ed and MindMelt) 
• desoxypipradol (found in the legal high product 
WHACK) 
• luorotropacocaine (also found in the legal high 
product WHACK) 
• aminotetralins and aminoindans (contained in the 
legal high product Pink Champagne) 
• bromo-dragonFLY 
• salvinorin A (found in the plant Salvia divinorum) 
• mitragynine and 7-hydroxymitragynine (found in the 
plant known as kratom).
www.dohc.ie/legislation/statutory_instruments/pdf/
si20110551.pdf
Coolmine Therapeutic Community annual report 2010
The Coolmine Therapeutic Community annual report for 
2010 contains information relating to the organisational 
highlights, statistics, past client stories, partnerships and 
fundraising, and ﬁ nancial statements (www.coolmine.ie/
about-us/downloads). 
According to the report, CTC is continuing to build capacity 
to facilitate detoxiﬁ cation and has recruited a clinical nurse 
specialist. There was an increase in the number of referrals 
and admissions of women with young children to the 
residential programme at Ashleigh House. The refurbishment 
of 19 Lord Edward Street was completed, and stabilisation 
and drug-free day programmes moved back there. Coolmine 
staff were trained in the community reinforcement approach 
(CRA) to working with individuals and their families. A 
training and education programme was established at 
Coolmine which is managed by the career guidance 
counsellor. 
In 2010 Coolmine worked with 1,161 people:
• The Outreach team worked with 822 clients 
spanning both residential and day programmes. 
• The Drug Free Day Programme worked with 51 
clients.
• 50 clients accessed the Welcome Programme.
• The Women’s Residential Service at Ashleigh House 
admitted 42 women, of whom ﬁ ve had their children 
permanently on site. Seven women completed a 
detoxiﬁ cation programme. 
• The Men’s Residential Service at Coolmine Lodge 
admitted 76 men, of whom 13 completed a 
detoxiﬁ cation programme. 
• Family Support Services provided supports to 120 
family members. 
• 73 clients secured housing, including emergency, 
transitional, private, step-down and supported long-
term accommodation.
• 92 clients were supported by the career guidance 
service. 
The priorities for Coolmine in 2011 include a review 
of the strategic plan, maintaining stafﬁ ng levels, the 
commencement of a longitudinal research programme and 
the continued integration of evidence-based practices within 
the Community.
(Contributors Jean Long and Anne Marie Carew)
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Latest NDTRS drug treatment data now 
available on line 
New drug treatment data for 2009 and 2010 from the 
National Drug Treatment Reporting System (NDTRS) are 
now available on line through the National Documentation 
Centre on Drug Use (NDC) website at 
www.drugsandalcohol.ie. The addition of this new data 
means that there are now seven years of drug and alcohol 
treament data available through the NDTRS interactive 
tables. Once on the site, click on the TREATMENT DATA tab.
You will be asked to log in. If you do not already have an NDC account, you can create one now.
You will be asked to accept a number of terms and 
conditions of use. This is needed to protect the identity of 
clients included in the NDTRS. We also ask that the NDTRS 
is acknowledged when data from the tables are used in 
a publication or presentation, and that the NDC receives 
copies of any publication in which these data are used.
When interpreting the data, it should also be remembered 
that each NDTRS record relates to a treatment episode (a 
case) and not to a person, as there is currently no unique 
health identiﬁ er. This means that the same person could be 
counted more than once in the reporting year if they had 
more than one treatment episode in that year.
You can run different analyses on the treatment data based 
on up to eight different types of drug, including alcohol, 
in various combinations. The variables available for analysis 
include year, age group, gender and geographical region of 
residence (county, HSE region, LHO, regional or local drugs 
task force area). Your analysis can then be exported into 
Excel.
For further information contact the NDC at 01 2345 175 or 
at ndc@hrb.ie 
(Suzi Lyons and Brian Galvin)
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 Drugnet Ireland 10 years on: what have 
we learned?
The Health Research Board published the ﬁ rst issue of 
Drugnet Ireland in 2001. The 40 issues published since then 
have, we hope, contributed to our readers’ understanding 
of the scientiﬁ c, social, political, educational and economic 
issues which impact on the drugs situation in Ireland. 
Drugs policy, from the formulation of government 
strategic objectives to the choice of interventions made 
by service providers, is shaped by information which is 
often concise and pertinent but sometimes contradictory 
and impenetrable. It has been our task to alert you to 
new information, to make it understandable and to 
explain its relevance. We will continue to contribute to 
public understanding of drug-related issues to inform an 
increasingly sophisticated and rigorous public debate, and 
present evidence needed by practitioners and policy makers 
in an accessible form.
The ﬁ rst Drugnet Ireland was published shortly before the 
launch of a drugs strategy committed to the development 
of the evidence base on drugs issues and pursuance of 
policies based on this knowledge. In this article we reﬂ ect on 
what has actually been learned over the past 10 years and 
what changes in research practice and output have made 
a difference. We look forward to your continued support in 
2012.
Drug prevalence among the general and school-aged 
populations
Drug prevalence surveys of the general and school-aged 
populations are important sources of information on patterns 
of drug use, and, when repeated, reveal changes over time. 
These surveys increase understanding of drug use, which, in 
turn, help in the formulation and evaluation of drug policies. 
They also enable informed international comparisons, 
provided countries conduct surveys in a comparable manner. 
There are two key drug prevalence surveys undertaken in 
Ireland.
The All-Ireland Drug Prevalence Survey, ﬁ rst administered 
in 2002/3 and twice subsequently (2006/7 and 2010/11), 
seeks to obtain prevalence rates for the more commonly 
used illegal drugs, such as cannabis, ecstasy, cocaine and 
amphetamines, on a lifetime (ever used), last year (recent 
use), and last month (current use) basis. Similar prevalence 
questions are also asked of alcohol, tobacco, and other 
drugs such as sedatives, tranquillisers and anti-depressants. 
Attitudinal and demographic information is also sought from 
respondents. In the most recent survey, measures to assess 
the prevalence of dependence on cannabis were included. 
The questionnaires are administered through face-to-face 
interviews with respondents aged between 15 and 64 
normally resident in households in Ireland and Northern 
Ireland. Thus, persons outside these age ranges, or who 
do not normally reside in private households, are not 
included in the survey. This approach excludes those living 
in institutions (for example, prisons, hostels). Therefore this 
type of survey is not a good measure of drug use among 
marginalised populations, nor of drugs that are more 
commonly used among such populations, such as crack 
cocaine or heroin; different research approaches are required 
among such groups. Bulletins reporting the ﬁ ndings of all 
three iterations have been published and can be found at 
www.nacd.ie/publications/index.html
The European School Survey Project on Alcohol and Other 
Drugs (ESPAD) is a collaborative effort of independent 
research teams in about 40 European countries, including 
Ireland. Data on alcohol and illicit drug use among 
15–16-year-olds have been collected every four years 
since 1995, using a standardised method and a common 
questionnaire. Data were collected for the ﬁ fth iteration 
of ESPAD in spring 2011 and the survey ﬁ ndings will be 
published in 2012. The rationale for the survey is that school 
students are easily accessible and are at an age when onset 
of substance use is likely to occur. By deﬁ nition, early school 
leavers, a group known to be vulnerable to alcohol and 
drug use, are not represented. The ESPAD survey reports are 
available at www.espad.org/espad-reports
Problem drug use
‘Problem drug use’ is deﬁ ned by the European Monitoring 
Centre for Drugs and Drug Addiction (EMCDDA) as 
‘injecting drug use or long duration/regular use of opioids, 
cocaine and/or amphetamines’. This deﬁ nition includes 
regular or long-term use of prescribed opioids such as 
methadone but does not include their rare or irregular 
use or the use of other drugs, such as ecstasy or cannabis. 
Currently, estimates of problem drug use in Ireland are 
limited to  opioid use, using three-source capture–recapture 
methods for 2001, 2002 and 2006 (Kelly et al. 2003, 2009); 
owing to methodological limitations, the 2006 estimated 
ﬁ gures are likely to be inﬂ ated. In 2010 the National 
Advisory Committee on Drugs (NACD) commissioned 
the Centre for Drug Misuse Research at the University of 
Glasgow to examine the methods and data sources available 
to estimate the prevalence of problem opiate and cocaine 
use. The researchers recommend that the best national 
estimate of problem opiate use can be obtained using four 
national datasets and that the capture–recapture estimate 
begin at county level and build to national level. This 
estimate would be validated using the multiplier method 
and multiple indicator method. 
Drug-related infectious diseases
Problematic drug use can be associated with a number 
of other health conditions or lead to a range of health 
consequences, including drug-related infectious diseases. 
This key indicator collects data on the incidence and 
prevalence of, primarily, HIV, hepatitis C and hepatitis B 
infection among people who inject drugs. The incidence 
data are collected through routine surveillance of newly 
diagnosed cases which identiﬁ es injecting drug use as a 
risk factor, or through cohort studies. In Ireland the Health 
Protection Surveillance Centre (HPSC) has recorded new 
cases of HIV among injecting drug users since 1985, and of 
hepatitis B since 2004 and hepatitis C since 2007. Reporting 
to the HPSC of risk factors for HIV cases and hepatitis C cases 
is high, but for hepatitis B is much lower than desirable. 
The prevalence of HIV, hepatitis B and hepatitis C among 
injecting drug users has not been reported since 2002.
Early warning system and emerging trends 
Established in 2001, the Early Warning and Emerging 
Trends Sub-Committee of the NACD advises the Irish 
government on emerging drug trends or practices and their 
consequences. The members of the committee are recruited 
from a wide range of government departments, professional 
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disciplines and services, including police and customs, 
human, chemical and forensic toxicology, pharmacology 
and pharmaceutical science, emergency medicine, drug 
treatment, harm reduction, public information and research, 
including the EMCDDA’s national focal point in Ireland, 
which is located within the Health Research Board. 
Treatment
In the early years of Drugnet Ireland one of the dominating 
issues in drug treatment was problem opiate use and the 
provision of opiate substitution treatment. 
The ROSIE study, commissioned by the NACD, was Ireland’s 
ﬁ rst national, prospective, longitudinal drug treatment 
outcome study. The main objective was to ‘evaluate the 
effectiveness of treatment and other intervention strategies 
for opiate use in Ireland’. In 2003/04, 404 opiate users 
who entered treatment were recruited and, of these, 289 
(72%) completed the follow-up questionnaires one year and 
three years later. Despite methodological limitations, the 
overall results showed positive outcomes for opiate users in 
treatment over the three-year period, including a reduction 
in the use, number and amount of drugs; an increase in 
abstinence; a decrease in the proportion of participants 
who were homeless; and an increase in the proportion who 
were in employment over the three-year period. Since the 
study was completed its results have been used to inform a 
number of strategies, in addition to providing a wide range 
of additional information through numerous journal articles. 
The reports on the ROSIE study are available at www.nacd.ie 
In response to the heroin problem in Dublin and, in 
particular, concern about the spread of HIV, the ﬁ rst Irish 
methadone treatment protocol (MTP) was published 
in 1998. The protocol has been reviewed internally 
(Methadone Prescribing Implementation Committee 2005) 
and externally (Farrell and Barry 2010). The external review 
concluded that the original protocol had achieved its aims, 
particularly in regulating and improving poor prescribing 
and quality practices. These improvements occurred against 
a background of increasing numbers receiving methadone 
and increasing availability of methadone treatment. The 
number of continuous care clients attending methadone 
treatment, as recorded in the Central Treatment List has 
steadily increased, from 3,681 in 1998 to 8,727 in 2010. 
The numbers of clients attending Level 1 GPs and receiving 
methadone in prison have also increased over the same 
period. 
The external review of the MTP also recommended that 
buprenorphine/naloxone should be routinely available as 
a treatment option, to which end the review was entitled 
The introduction of the opioid treatment protocol. Other 
recommendations included expanding clinical governance 
and audit, increasing the number of Level 2 GPs, reviewing 
the current urinalysis regime, creating guidelines of 
treatment in Garda stations, and improving data collection 
and analysis.
Drug-related deaths
An issue associated with problem opiate use is drug-related 
deaths. For several years prior to 2005 a theory had been in 
circulation that the number of drug-related deaths in Ireland 
was being under-recorded. This theory was supported by 
a number of small studies, one in particular (Byrne 2001, 
2002) which found that annual numbers of opiate-related 
deaths recorded by the Dublin coroners were consistently 
higher than those recorded in the General Mortality 
Register. In addition, families of substance users in Dublin, 
through the auspices of the Family Support Network, had 
been calling for an accurate measurement of the extent of 
premature death among drug users.
Action 67 of the 2001–2008 National Drugs Strategy called 
for the development of a system for recording drug-related 
deaths and deaths among drug users to enable the State and 
its agencies to respond in a timely manner, with accurate 
data. In compliance with this action, the Irish National Drug-
Related Deaths Index (NDRDI) was established in September 
2005. The strength of the NDRDI is that it records data from 
four sources – the Coroner Service, the Hospital In-Patient 
Enquiry scheme (HIPE), the Central Treatment List (CTL), and 
the General Mortality Register (GMR) – in order to ensure 
that the database is complete and accurate. To date, the 
NDRDI has shown that the number and extent of drug-
related deaths in Ireland is increasing, and the data have 
been used to inform policies at both national and European 
levels. Reports on the data collected in the NDRDI are 
available at www.hrb.ie 
Problem alcohol use
One issue that has come to the fore in recent years is the 
extent, and effects, of problem alcohol use among the Irish 
population. The National Drug Treatment Reporting System 
(NDTRS), established in 1990, was originally designed to 
record problem drug use and only recorded problematic 
use of alcohol in cases where it was an additional problem 
substance. In 2004, the remit of the NDTRS was extended 
to include cases who reported alcohol as their main or only 
problem drug. These data provide valuable information and 
improve our understanding of the extent of the problem, 
the characteristics of those seeking treatment, and trends 
in treatment over time. Reports on the data collected in the 
NDTRS are available at www.hrb.ie 
The remit of the NDRDI was also extended, and the index 
has now retrospectively collected information on alcohol-
related poisoning deaths and deaths among those who were 
alcohol dependent, which, together with the treatment 
data, increases our understanding of the burden of problem 
alcohol use in Ireland today. In the future, these databases 
will allow us to measure the impact of any national policy 
changes on alcohol-related harm in the Irish population. 
Drug prevention
Research on risk and protective factors
In one of the ﬁ rst reviews of research on the prevention of 
drug use published in Ireland, Morgan (2001) summarised 
the factors that increase the risk of substance use among 
young people. He identiﬁ ed a number theoretical categories 
and the context in which the risk factors in these categories 
arose, including the individual’s interactions with family, 
peers, schools and communities. A number of these 
categories relate to the social and interpersonal sphere, 
culture or attitudes that young people experience in their 
immediate environments. 
 ■ The lack of commitment and social attachment category 
emphasises the risks associated with deviant impulses 
which are not held in check when bonds to society, 
families, schools and belief systems are weakened. 
 ■ The social cognitive learning theory category refers to the 
risks associated with young people’s acquisition of their 
beliefs and behaviours from signiﬁ cant others, such as 
parents, peers and media celebrities. 
 ■ The family interaction theory category underlines the risk 
of maladjustment when a young person’s parents fail to 
exhibit conventional values or norms or provide affection 
or discipline. 
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 ■ The communal risk factors category highlights how young 
people are disincentivised to commit to conventional 
norms and society when communities are disorganised 
and crime and unemployment are common.
Some theoretical categories emphasise those intrapersonal 
characteristics and biological predispositions which increase 
risk. 
 ■ The biological models of vulnerability category stresses 
genetic susceptibility and inherited characteristics. 
 ■ The self-derogation and substance use category explains 
how negative evaluations, by self and others, result in 
poor self-esteem and greater risk. 
 ■ The problem behaviour theory category focuses on the 
behaviour itself rather than on causative factors. It 
demonstrates how one form of problem behaviour, 
such as rebelliousness, is associated with other types of 
problem behaviour.
A recent study by Haase and Pratschke (2010) examined the 
association between a number of risk factors and substance 
use among a group of early school leavers and a group of 
school attendees. The ﬁ ndings aligned with several of the 
theoretical categories identiﬁ ed by Morgan. For example, 
Haase and Pratschke found evidence of family and peer 
inﬂ uence on young people’s behaviours, including both 
risk and protective factors, which was consistent with both 
social cognitive learning theory and family interaction 
theory. They also found evidence consistent with problem 
behaviour theory, e.g. aggressive behaviour or ‘acting-out’ 
and substance use, and strong interactions between the 
use of different substances. The connection between low 
self-concept or self-esteem and substance use posited by 
self-derogation and substance use theory was demonstrated 
by the increased likelihood of smoking cigarettes among 
both early school leavers and school attendees. 
Universal prevention in schools
Research done by young people from the Dáil na nÓg 
Council for the Ofﬁ ce of the Minister for Children and Youth 
Affairs (2010) on the experience of post-primary school 
students receiving Social Personal and Health Education 
(SPHE) found that 83% indicated that alcohol, drug and 
solvent use was the most emphasised theme in the SPHE 
syllabus. The study identiﬁ ed a number of beneﬁ ts from 
participating in the SPHE programme: learning how to make 
decisions and the chance to discuss interesting subjects were 
regarded as beneﬁ ts by more than half the participants; 
nearly half reported improved self-respect and improved 
emotional and physical health and well-being, while slightly 
fewer had developed personal and social skills and had 
improved mental health and well-being.
A study of the contribution of the SPHE curriculum to 
the experience of junior cycle students and to the junior 
cycle curriculum (Nic Gabhainn et al. 2007) found that 
it contributes positively to students’ attitudes to health, 
especially in their future lives. SPHE helps students to think 
about and discuss health issues relevant to their age group; 
it also provides opportunities to develop personal and social 
skills.
Selective prevention in schools
Smyth and McCoy (2009) undertook interviews with 
parents, children and principals from DEIS (Delivering 
Equality of Opportunity in Schools) schools, and with key 
professionals working in a range of educational bodies and 
statutory organisations and a national postal survey of school 
principals. The DEIS programme is a targeted intervention 
delivered in communities that have been identiﬁ ed as having 
higher than average scores on a number of indices used to 
assess the extent of disadvantage. This targeted approach 
can in theory deal with problems more directly than the 
universal approach. However, the evidence in the report 
indicated that the problems faced by children attending 
DEIS schools were so great in number and intensity that 
the number of families that might beneﬁ t from the DEIS 
programme could be quite small.
Social exclusion and social reintegration of drug users
Employment and vocational education
Research showed a fall between 2001 and 2006 in the 
percentage of treatment contacts in employment, despite 
unprecedented economic growth in the country over this 
period. Two separate reviews of measures taken to improve 
the employability of recovering drug users through the FÁS 
Special Community Employment scheme concluded that 
the scheme was less focused on improving employability 
and more inclined to operate in a crisis management mode 
by providing generic support to recovering drug users. The 
Bridge-to-Workplace, an inter-agency initiative developed 
to help recovering drug users return to education or secure 
work placement in the labour market, reported that between 
August 2005 and December 2006 over half of participants 
had completed or were engaged in a work placement. 
Homelessness and drug use
The evidence base on the association between homelessness 
and drug use in Ireland improved considerably during the 
last decade. In particular, the factors that lead some young 
people into homelessness have been documented in a 
number of studies. Studies with homeless young people in 
Dublin and in Cork (Mayock and Vekic 2006; Mayock and 
Carr 2008) reported that being in state care, experiencing 
abusive family situations and developing problem behaviours 
constituted their pathways into homelessness; once 
homeless, their substance abuse often exacerbated their 
experience and led to episodes of insecure accommodation 
and engagement in high-risk behaviours. Follow-up 
interviews with the young people in Dublin showed that 
young people who maintained supportive contact with 
their families were able to access treatment and make the 
transition to supportive living conditions. On the other hand, 
young people with weak family ties and poor education 
were more likely to remain trapped in homelessness and 
substance misuse. The legacy of becoming trapped in 
homelessness was vividly captured in a recent snapshot 
study of homeless adults using the services of the Simon 
Communities of Ireland (2010): study participants reported 
high levels and different combinations of alcohol and illicit 
drug use; physical and mental health problems were also 
prominent among these people and many had spent long 
periods in homelessness. 
Drugs and crime, drug markets and supply reduction
The National Drugs Strategy 2001–2008 and the National 
Drugs Strategy (interim) 2009–2016 both sought to address 
the harm caused to individuals and society by drug misuse 
through a concerted focus on supply reduction, prevention, 
treatment, rehabilitation and research. The research pillar 
of the two strategies has sought to eliminate gaps in 
knowledge so as to ensure that policy is evidence based.
Although the link between drugs and crime has been ﬁ rmly 
established in the public consciousness in Ireland, there has 
been little sustained examination of the precise nature of this 
link. Murphy (in O’Mahony 2002) suggests that, in Ireland, 
‘the notion of a deﬁ nite causal connection between drugs 
and crime is assumed rather than examined’ (p. 202). 
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The primary focus of research in this area has been on 
examining the economic motivation model of drug-related 
crime, which emphasises the way in which drug dependency 
ampliﬁ es offending behaviour, particularly in relation to 
property crime and other crimes such as prostitution. The 
economic model also highlights the way in which the 
control of heroin use through closely supervised treatment 
can lead to a reduction in both drug use and crime. The 
NACD ROSIE study, mentioned in a previous section, has 
provided strong evidence that treatment reduces the level of 
crime. 
Other aspects of the drugs–crime nexus remain under-
researched – for example, the links between illicit drug use 
and driving offences, alcohol use or illicit drug use and 
violent crime, polydrug use and offending, and drug-use, 
drug-related crime and gender.
Another aspect of drug-related crime highlighted in the 
literature is ‘systemic crime’, i.e., crime associated with the 
illicit drug market. Knowledge about how the illicit drug 
market operates is an important prerequisite for effective 
interventions and responses to it. Although the issue of 
drug-related ‘gangland’ violence has received a great deal 
of media attention and has been the subject of numerous 
journalistic exposés, until recently Ireland’s illicit drug 
markets have not been the subject of any in-depth research 
and analysis. A recent study on Dublin’s crack cocaine 
market (Connolly et al. 2008) and a forthcoming national 
study published by the NACD and the HRB (Connolly et al., 
in press) have begun to address this gap. Studies of illicit 
drug markets are, by their very nature, difﬁ cult to conduct. 
They require researchers to negotiate access to participants 
in illicit drug markets, both those involved in the production 
and distribution of drugs and professionals responding to 
them. They also require the regular compilation of key data 
sources such as drug seizures, drug prices and drug purity 
analysis for example.
The last 10 years have also seen a signiﬁ cant intensiﬁ cation 
in the response of law enforcement agencies to drug-related 
crime. The Garda National Drugs Unit was established in 
1994, and a broad range of legislative provisions has been 
introduced, including the establishment of the Criminal 
Assets Bureau, changes to Garda detention and investigation 
powers, and to the laws on bail and, more recently, 
legislation tackling organised crime. The emergence of a 
number of local community policing partnerships in Dublin 
has also been a positive development, with a commitment in 
the 2009–2016 drugs strategy to establish similar fora in all 
local drugs task force areas.
Drug law enforcement activities may have contributed to the 
relative containment of illicit drug use, and the authorities 
have had some success in disrupting drug markets and 
dismantling organised crime groups. However, there is little 
evidence in Ireland or internationally that such strategies 
have halted the expansion of the illicit drug market or 
reduced the criminal activities associated with it for any 
sustained period of time. Indeed, the consistent demand 
for illicit drugs often ensures that the removal of one drug 
trafﬁ cker creates a vacuum which is inevitably ﬁ lled by 
another. 
A recent international review of evidence-based drug policy 
(Babor et al. 2010) reached the stark conclusion that ‘there 
is virtually no scientiﬁ c research to guide the improvement of 
supply control and law enforcement efforts… Independent 
of how strongly a policy maker values law enforcement and 
supply control as policy tools, it is difﬁ cult to understand 
why policymakers would not want their policies to be based 
on good quality evidence. The lack of careful study thus 
continues to pose a major barrier to applying these policies 
effectively’ (p. 258).
Finally, with regard to penal policy, in his seminal study, 
Mountjoy prisoners: a sociological and criminological proﬁ le 
(1997), Paul O’Mahony found that 63% of prisoners had 
a serious dependency on a ‘hard drug’, the average age of 
ﬁ rst imprisonment was just under 19 years, and there were 
high rates of recidivism, with prisoners having served an 
average of ten prison sentences. Fifty-six per cent of the 
prison population came from six areas in Dublin that were 
characterised by severe levels of socio-economic deprivation 
and chronic unemployment. The majority still lived with 
their parents or other relatives, were from large and often 
broken families, with 80% having left school before the 
legal minimum age of 16, and 88% of prisoners having 
been unemployed prior to their imprisonment. A more 
recent study on prison recidivism (O'Donnell et al. 2007) 
has conﬁ rmed that the general proﬁ le of the Irish prison 
population remains largely unchanged. Although health 
services for dependent drug users in Irish prisons have 
improved signiﬁ cantly in the past ten years, such services are 
often provided in overcrowded conditions as the numbers in 
prison have increased by almost 100% in the past 14 years.
National policy framework 
Notable developments in Ireland’s National Drugs Strategy 
(NDS) since 2001 have included the expansion of the four 
pillars to include rehabilitation alongside treatment and 
harm reduction, and recognition of the role of families in 
tackling the drugs problem. These developments happened 
on foot of the mid-term review of the ﬁ rst NDS in 2004/5 
and the review at the expiry of this same NDS in 2008. 
While the ﬁ rst NDS included an action calling for a mid-term 
review, the second NDS, covering 2009–2016, does not 
include any actions calling for either a review at the mid-way 
point, in 2012, or an evaluation when the strategy expires in 
2016. 
The top drug-related policy priority for the government 
currently is how to combine drug policy with alcohol policy, 
responsibility for both of which rests with the Department 
of Health. As well as the growing body of research evidence 
highlighting the problematic aspects of alcohol use in 
Ireland, noted in a previous section, several regional drugs 
task forces, in their ﬁ rst strategic and/or action plans 
completed in 2005, acknowledged the problems associated 
with alcohol misuse in their areas and included speciﬁ c 
responses in their plans. Public consultations on the NDS 
have also routinely raised the issue of problem alcohol use. 
An announcement on the preferred approach to combining 
the policies was expected as this issue of Drugnet Ireland 
went to press.
Ever since a recommendation by the Ministerial Task Force 
on Measures to Reduce the Demand for Drugs (1996), 
Ireland’s drugs policy and strategy have been located within 
the wider policy context of social inclusion. As a result, 
successive national anti-poverty strategies, social partnership 
agreements and national development plans have all 
impacted on the design and delivery of drug policies. The 
adoption of a lifecycle framework for social policy, following 
publication of the National Economic and Social Council 
(NESC) report The developmental welfare state in 2005, has 
had implications not only for the delivery of drug-related 
policies but also for drug-related research. Longitudinal 
studies are now required in order to assess accurately the 
impact of policies on individuals over the course of their 
entire lifetime.
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Following the reorganisation of drug-related policy functions 
in early 2011, the new government’s view on the wider 
policy context of the drugs issue has become less clear. Prior 
to the February election, responsibility for drugs policy was 
located in the same government department as community 
and local development, equality and social inclusion policy, 
suggesting a common goal or shared aspiration among all 
these policy domains. The new government has separated 
these four policy areas and assigned them to four different 
government departments. How the Department of Health 
will co-ordinate implementation of the national drugs 
strategy remains to be seen.
Over the past decade Ireland’s drug and alcohol policy 
frameworks have been the focus of academic research and 
critical commentary. Since the publication of Shane Butler’s 
Alcohol, drugs and health promotion in modern Ireland (2002), 
there has been a steady trickle of studies around the need 
to move Ireland’s policy responses away from concepts such 
as the ‘disease model’ of alcoholism or the ‘war on drugs’ 
to exploring how a health promotion, or more recently, 
a population health, model might be applied (Butler and 
Mayock 2005; O’Shea 2007;  Cullen 2011; Randall 2011). In 
The Irish war on drugs: the seductive folly of prohibition (2008), 
criminologist Paul O’Mahony argued that Irish society would 
make substantial gains from accepting the libertarian view 
that there is a right to use drugs so long as others’ rights 
are not infringed. He suggested that a non-coercive harm 
reduction approach could eliminate many of the ill-effects 
of prohibition and create a positive attitudinal dynamic that 
lowers the irresponsible and destructive use of drugs.
The policy process itself has also been the focus of attention. 
Brigid Pike (2008) reviewed Ireland’s ﬁ rst national drugs 
strategy as a ‘policy instrument’, in order to gain insights 
into how structural elements such as the hierarchy of aims 
and objectives or governance arrangements might inﬂ uence 
the strategic outcomes. She highlighted underlying tensions 
in the areas of goal-setting, information gathering, co-
ordination, and responding to changing circumstances 
and needs, which have the potential to adversely affect 
outcomes. In a study of the research/policy interface and the 
extent to which drug policy in Ireland might be deemed to 
be a rational, evidence-based process, Niamh Randall (2011) 
concluded that drug-related policy making in Ireland is 
unlikely ever to attain the degree of rationality suggested by 
the managerialist rhetoric of the national drugs strategy. 
(Johnny Connolly, Brian Galvin, Martin Keane, Jean Long, Suzi 
Lyons, Brigid Pike)
The bibliography for this article is included in the 
electronic version of this issue and in the article as posted 
on the National Documentation Centre website, both 
available at www.drugsandalcohol.ie  
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Service providers accredited in 
Community Reinforcement Approach 
On Friday 7 October 2011, 83 front-line service providers 
working in the substance use ﬁ eld received accreditation as 
trained practitioners in the delivery of a number of evidence-
based positive reinforcement approaches that address 
substance use: 52 received accreditation in the Community 
Reinforcement Approach (CRA), 19 in the Adolescent 
Community Reinforcement Approach (ACRA) and 12 in 
Community Reinforcement and Family Training (CRAFT). 
The graduation event, held in the Grand Hotel Malahide, 
was the culmination of a two-year implementation plan by 
Blanchardstown Local Drugs Task Force to introduce the 
use of the CRA model. The plan involved training nearly 
200 frontline workers from a range of sectors, disciplines 
and agencies across the task force area and some regional 
areas and was funded by the HSE Social Inclusion Unit. The 
graduates all completed an intensive process which involved 
training, supervision groups and assessment, by external 
coders in the US, of recorded CRA sessions with clients.
Chairman of the task force, Mr Tony Geoghegan, opened 
the event and spoke of the task force’s commitment to 
‘supporting agencies in the areas under the task force to 
use evidence-based approaches to respond to the needs of 
clients [and] to empower workers in agencies by providing 
them with accredited training’. Brid Walsh, co-ordinator 
of the task force, thanked her team for their hard work in 
implementing the plan to bring CRA to the task force areas 
and for organising the graduation event, giving a special 
mention to Ciara Jubani and Louise McCulloch. Ms Walsh 
said that the people who had been trained and accredited 
‘had bought into the positive reinforcement approach, as it 
was about providing a quality service to clients’. Dr Robert 
Meyers from the US, who was instrumental in building 
on earlier versions of the approaches and who trained all 
the accredited participants, remarked on the enthusiasm, 
dedication and professionalism displayed by all participants 
during their training and assessment and congratulated 
them on their achievements. He observed that they were 
the largest group to have been trained and accredited in the 
CRA approach anywhere in the world. 
An article by Dr Meyers and colleagues1 describes CRA as ‘a 
cognitive-behavioral intervention that was founded on the 
belief that environmental contingencies play a critical role 
in encouraging or discouraging substance abuse. …[the 
approach uses] community (i.e., familial, social, recreational 
and occupational) reinforcers to support change in an 
individual’s drinking or drug using behaviors.’
(Martin Keane) 
1. Meyers RJ, Villanueva M and Smith JE (2005) The 
Community Reinforcement Approach: history and new 
directions. Journal of Cognitive Psychotherapy, 19(3): 
247–260.
Dr Bob Meyers with some of those who chaired trainee 
accreditation groups (l to r):  Yvonne Booth, Sean Foy, 
Suzanne White, Gemma Collins, James Kelly, Catherine 
Meleady, Kevin Ducray and David Madden.
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Review of motivational interviewing in 
addressing substance abuse 
Motivational interviewing (MI) is acknowledged in the 
National Drugs Strategy (NDS) as an effective evidence-
based intervention in the treatment of alcohol and stimulant 
abuse. The NDS also promotes the training and up-skilling of 
addiction counsellors to deliver MI to clients. 
Smedslund and colleagues1 undertook a systematic review of 
randomised controlled trials that assessed the effectiveness 
of MI in reducing drug use, improving retention in treatment 
and readiness to change, and reducing the number of 
repeat criminal convictions. The authors provide a useful 
description of how MI is intended to work, and describe four 
key strategies that addiction counsellors employ: 
 ■ The counsellor expresses empathy with the client; they 
try to see the world through the eyes of the client.
 ■ The counsellor supports self-efﬁ cacy; they give 
responsibility to the client for choosing and undertaking 
actions to change.
 ■ The counsellor rolls with resistance; they do not ﬁ ght 
with client’s resistance or ambivalence to change, they 
continue to assist clients to further explore statements 
that signal ambivalence.
 ■ The counsellor develops discrepancy; they assist the 
client to perceive a discrepancy between their current 
behaviour and their future goals and aspirations. 
Fifty-nine trials undertaken between 1993 and 2010 
covering 13,342 participants were included in the review; 
57 were RCTs and two were quasi-RCTs. Twenty-nine trials 
involved alcohol abusers, eight involved cannabis abusers, 
four involved cocaine abusers, and 18 involved abusers of 
more than one substance. Only trials that included video or 
sound recordings of the intervention being delivered were 
included, to ensure that the intervention provided was in 
fact MI. 
 The authors found that people who received MI reduced 
their use of alcohol and drugs more than people who 
did not receive any treatment. The effect was strongest 
immediately following treatment and became progressively 
weaker at short-term (up to ﬁ ve months), medium-term (6–
11 months) and long-term follow-up (12 months or more). 
The authors conclude that delivering MI to reduce substance 
abuse is more effective than doing nothing. Compared with 
interventions such as giving feedback on assessments or 
other types of psychotherapy, MI did not prove superior or 
inferior in reducing substance abuse. There were insufﬁ cient 
data in the trials to reach conclusions about the effects of 
MI on retention in treatment, readiness to change, or repeat 
convictions. The authors signal concern about the quality 
of the research available on the effectiveness of MI and call 
for a degree of caution to be applied when reading their 
conclusions in this review. 
(Martin Keane)
1. Smedslund G, Berg RC, Hammerstrøm KT, Steiro 
A, Leiknes KA, Dahl HM et al. (2011) Motivational 
interviewing for substance abuse. Cochrane Database 
of Systematic Reviews. http://onlinelibrary.wiley.com/
doi/10.1002/14651858.CD008063.pub2/abstract
Employment and drug use: an emerging 
evidence base
Bauld et al. (2010) undertook a study on behalf of the 
Department of Work and Pensions (UK) to examine the 
issues surrounding beneﬁ t uptake by individuals who 
use illicit drugs, particularly heroin and/or crack cocaine. 
The study also explored the wider context of education, 
training and employment for drug users, as well as the 
role of treatment. The study included two components: 
a comprehensive but non-systematic review of relevant 
literature and semi-structured interviews with 75 individuals, 
54 male and 21 female, who were current or recent users 
of drug treatment services in ﬁ ve separate case study areas 
in the UK. Ten service providers from the ﬁ ve locations were 
also interviewed. This article will present the ﬁ ndings from 
the interviews with the 75 individuals. 
Education and training proﬁ le 
Most of the people interviewed had left school with few 
qualiﬁ cations. Their early-school experiences included school 
expulsion, episodes of truancy, being the victim of bullying 
and dealing with dyslexia. Several reported returning 
to vocational training when they left school and some 
managed to achieve vocational qualiﬁ cations. However, 
most remained poorly qualiﬁ ed for the labour market and 
lacked many of the skills sought by employers. Some felt 
their employment prospects were restricted by having had 
a poor education and the fact that they had few skills and 
qualiﬁ cations.
Employment and beneﬁ ts history
Most of the people interviewed were not in paid legal 
employment but many were involved in volunteering, 
with some in drug and alcohol services. Volunteering was 
perceived as very beneﬁ cial in that it provided opportunities 
to move into employment and assisted with recovery. 
Volunteering allowed them to test out their ability to work, 
and also enabled them to give something back to their 
community and help support others in a similar position.
Most had worked at some point in the past, some for longer 
periods than others. A small number had advanced work-
related knowledge and skills and had secured meaningful 
employment, while others with few vocational skills were 
conﬁ ned to working in unskilled jobs. All interviewees were 
either currently in receipt of beneﬁ ts or had received them in 
the past, these included incapacity beneﬁ t, income support 
and job-seekers allowance. 
Barriers to employment 
Interviewees were reported to be lacking in self-conﬁ dence 
and coping with poor mental health, including depression 
and anxiety. Related to their lack of self-conﬁ dence was a 
fear of relapse if they returned to work before they felt ready. 
They felt incapable of meeting the demands of returning to 
work and, for some, the idea of job-hunting was a daunting 
prospect. Some were daunted by the prospect of putting 
together a CV and attending interviews and trying to 
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account for long gaps in their CV and a lack of references. 
A common theme among interviewees was their concern 
that the physical health problems they suffered from, such 
as multiple sclerosis, back injuries and hepatitis C, might 
prevent them from ﬁ nding employment.
They also feared stigmatisation from potential employers 
because of their history of using drugs; related to this was 
uncertainly about how employers would deal with their 
receiving treatment while being employed. Other 
respondents worried about the side effects of medication 
compromising their ability to work properly.
Interviewees admitted to involvement in shoplifting, 
burglary, drug dealing and fraud as a means of obtaining 
money for drugs. Most admitting having done cash-in-hand 
work and some had been involved in prostitution. 
Future aspirations
Almost all the people interviewed expressed the view that 
becoming drug free was a higher priority than coming off 
beneﬁ ts and getting a job. For many, this involved coming 
off a methadone prescription. On the other hand, some 
wanted to start taking methadone so they would be able 
to move into employment. According to the authors, this 
illustrates ‘just how personal ideas about what constitutes 
recovery are’.
The barriers to employment articulated by the people 
interviewed in this study are also to be found in a review of 
the literature by Cebulla and colleagues (2004). According 
to a recent report by Drugscope (2010), these barriers 
are consistently mentioned throughout the literature. In a 
number of evaluations of vocational training interventions 
published in Ireland that included the views of service users, 
similar ﬁ ndings emerged (Lawless and Cox 2000; Bruce 
2004; Lawless 2006). This type of consistent coverage of 
the salient barriers to employment for drug users signals 
a degree of consensus on what needs to be tackled by 
interventions if the employability of drug users is to improve. 
Conclusion
The research reported on here illustrates the nature of 
the challenge that faces both service users and providers 
when trying to improve the employability of people with 
drug-using histories. However, this is by no means an 
insurmountable challenge and for many people with drug-
using histories, their chances of returning to the labour 
market can be improved by services that focus on three 
key areas: personal development, education and quality 
vocational training, and consistent and effective treatment 
that leads either to abstinence or to a measure of stability 
that is meaningful to the client and reproducible over time. 
It must also be accepted that, for some people with drug 
using histories, their physical and mental health may be so 
compromised, that returning to employment may not be a 
feasible option. 
(Martin Keane)
Bauld L, Hay G, McKell J and Carroll C (2010) Problem 
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Research Report No. 640. Norwich: HM Stationery Ofﬁ ce.
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Employment and drug use (continued)
Update on drug-related deaths and 
deaths among drug users
National Drug-Related Deaths Index (NDRDI) ﬁ gures on 
drug-related deaths and deaths among drug users reported 
in 2009 are now available on the web.1 The ﬁ gures in this 
update supersede all previously published ﬁ gures. Similarly, 
ﬁ gures for 2009 will be revised when data relating to new 
cases becomes available.
For the ﬁ rst time, alcohol only poisonings are included in 
this analysis. Previously these cases have been reported 
separately.
In the six-year period 2004–2009 a total of 3,334 deaths 
by drug poisoning and deaths among drug users met 
the criteria for inclusion in the NDRDI database. Of these 
deaths, 2,015 were due to poisoning and 1,319 were due to 
traumatic or medical causes (non-poisoning) (Table 1).
Table 1 Number of NDRDI deaths, by year of death, NDRDI 2004 to 2009 (N=3,334)
  2004 2005 2006 2007 2008 2009
All deaths 422 481 540 612 641 638
Poisoning (n=2015) 267 300 325 385 381 357
Non-poisoning (n=1319) 155 181 215 227 260 281
Poisoning deaths in 2009
The annual number of deaths by poisoning increased from 
267 in 2004 to 381 in 2008, and dropped to 357 in 2009 
(Table 1). The majority of deaths in each year were of males, 
who accounted for 68% of the poisoning deaths in 2009. 
The majority of those who died in 2009 were aged between 
20 and 44 years; the median age was 37 years.
Just over half (51%) of all poisoning deaths involved more 
than one substance (polysubstance cases). The number of 
deaths where heroin was implicated rose to 108 in 2009, 
compared to 90 in 2008. Cocaine was implicated in 14% of 
deaths in the six-year period. The number of deaths where 
cocaine was implicated dropped to 52 in 2009, compared 
to 61 in 2008. In 2009, the number of deaths where 
methadone was implicated dropped to 66, compared to 80 
in 2008.
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Alcohol was involved in 40% of all poisoning deaths in the 
six-year period – more than any other substance. 
Prescription and over-the-counter medication was implicated 
in many cases. Benzodiazepines continued to play a major 
role in polysubstance poisonings.
In 2009 the highest number of poisoning deaths was 
recorded in the North Dublin City and County Regional 
Drugs Task Force area. The most signiﬁ cant increase between 
2008 and 2009, at 95%, was in the Mid West Regional 
Drugs Task Force area.
Non-poisoning deaths in 2009
The number of non-poisoning deaths increased by 81% over 
the reporting period, from 155 in 2004 to 281 in 2009. Of 
the 281 deaths in 2009, over half (56%, 157) were due to 
trauma and the remainder (44%, 124) were due to medical 
causes.
 2004 2005 2006 2007 2008 2009
Medical 42 44 81 87 111 124
Trauma 95 118 127 130 142 157
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Figure 1 Non-poisoning deaths among drug users, NDRDI 2004–2009 (N=1,258)
Deaths due to trauma
The number of deaths due to trauma increased annually, 
rising from 95 in 2004 to 157 in 2009 (Figure 1). The 
majority (82, 55%) of those who died in 2009 were aged 
under 35 years. The median age was 33 years. As in 
previous years, the majority (123, 78%) were male. The 
most common causes of death due to trauma in 2009 were 
hanging and choking.
Deaths due to medical causes
The annual number of deaths due to medical causes rose 
steadily over the reporting period, increasing from 42 in 
2004 to 124 in 2009 (Figure 1). The majority (57%) of those 
who died were aged between 30 and 49 years. The median 
age was 41 years. Males accounted for 71% (88) of those 
who died. The most common medical causes of death in 
2009 were cardiac events (42, 34%), respiratory infections 
(15, 12%) and cancer (13, 10%).
(Ena Lynn, Suzi Lyons and Simone Walsh)
1. Health Research Board (2011) Drug-related deaths and 
deaths among drug users in Ireland: 2009 ﬁ gures from the 
National Drug-Related Deaths Index. Available at www.
drugsandalcohol.ie/16365
Update on drug-related deaths (continued)
The national community detoxiﬁ cation 
initiative
The Community Detoxiﬁ cation Protocol was originally 
developed in response to a number of identiﬁ ed needs, 
including queries from some service users who found 
it difﬁ cult to access outpatient detoxiﬁ cation, and from 
medical professionals who noted some challenges in 
providing an outpatient detoxiﬁ cation in the absence of 
structured community support.1 
To address these issues, the Progression Routes Initiative 
brought together an interagency group in 2007 to develop a 
protocol, with members from the medical and community/
voluntary sector as well as service user representatives. 
The protocol outlined the minimum standards for delivery 
of interagency support for outpatient detoxiﬁ cation. This 
included medical support provided by prescribing doctors 
and psycho-social supports provided by key workers. A 
key person was nominated as the local ‘broker’ to raise 
awareness of the protocol and support engagement of local 
professionals in community detoxiﬁ cation. The protocol was 
successfully implemented as a pilot in Dublin’s North Inner 
City in 2008 and 2009.2,3
In November 2010, the Community Detoxiﬁ cation Steering 
Group reconvened and was expanded. The group includes 
representation from service user groups, research bodies, 
and medical, community and voluntary service providers.4 
The group reviewed and strengthened many aspects of the 
protocols, incorporating lessons learnt from the pilot in the 
North Inner City. 
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One of the main changes was the division of the 
protocol into two separate sets of guidelines, one for 
methadone detoxiﬁ cation and one for benzodiazepine 
detoxiﬁ cation.5,6 The protocols outline a structured, step-by-
step detoxiﬁ cation process for both benzodiazepines and 
methadone and clarify the roles of each stakeholder (service 
user, doctor and key worker) in the process. This includes 
guidelines on psycho-social supports and information to 
support prescribers to work under these protocols. 
While the minimum supports remain largely unchanged 
(weekly relapse prevention, care planning and regular 
medical appointments), certain areas of the protocols were 
bolstered to support the professionals who would work in 
line with them. Some of the changes include:
 ■ Separation of protocols: differences in risks, processes 
and structural contexts for benzodiazepine prescription 
and detoxiﬁ cation and for methadone prescription and 
detoxiﬁ cation are now reﬂ ected in two separate sets of 
protocol documents, one for each substance.
 ■ The detoxiﬁ cation process has been divided into four 
simple, logical steps with clear roles and responsibilities 
for each stakeholder in the process:
• Brokering, preparation, detoxiﬁ cation, aftercare.
 ■ Roles of the service user, key worker, doctor and broker 
clariﬁ ed:
• Provision of a comprehensive guide to the role of the 
local broker in the initiative.
 ■ Inclusion of additional guidelines, information and 
resources for prescribing doctors.
 ■ Comprehensive FAQ section which includes information 
on common queries, blocks and challenges encountered 
during community detoxiﬁ cation.
 ■ Comprehensive, service-user friendly information on 
risks involved in detoxiﬁ cation are incorporated in to an 
agreement form which is included in the protocols.
Structured, supported out-patient detoxiﬁ cation should be 
one of a range of safe and accessible treatment options open 
to those seeking support with substance dependence. The 
evaluation of the North Inner City Community Detoxiﬁ cation 
Pilot revealed a successful initiative with promising retention 
rates and stakeholder satisfaction.3 Due to interest from 
a number of areas in implementing the protocols and 
increasing numbers of referrals from outside the North Inner 
City, the new protocols and implementation structure will 
be adopted in a number of areas around Ireland as part of 
the National Community Detoxiﬁ cation Pilot 2012. The pilot 
was ofﬁ cially launched at the National Drugs Conference of 
Ireland 2011 and has so far received great support from the 
community/voluntary and medical sectors. The sites for the 
national pilot are: Cork/Kerry, the South East Regional Drugs 
Task Force (RDTF), the North Eastern RDTF, the Midlands, 
Bray, Ballymun, Ballyfermot, North Inner City Dublin and 
South Inner City Dublin.
Individuals from a variety of professions were nominated by 
each local or regional drugs task force to be trained in the 
role of broker for their area. Progression Routes delivered 
training in October 2011 and will provide an ongoing 
programme of support for independent brokers in the pilot 
areas. Over the coming two years, an evaluation will be 
conducted with the support of the evaluation sub-group, 
which includes expert input from the steering group. 
It is hoped that ultimately the Community Detoxiﬁ cation 
Protocols will ensure that health services and community 
drug services across the country have the tools to collaborate 
to provide an accessible, timely, practical and consistent 
approach to detoxiﬁ cation for service users seeking to 
reduce benzodiazepine or methadone use. They present 
a cost-effective way of maximising existing resources in 
the community/voluntary and statutory sectors to ensure 
a realistic detoxiﬁ cation option is available for people 
when they are ready to change. By using the protocols, all 
stakeholders can work together to achieve a positive impact 
on the experiences of service users seeking out-patient 
detoxiﬁ cation.
For further information please contact Ms Aoife Dermody 
in Progression Routes at aoife.dermody@aldp.ie or at 
01 878 6899.
(Aoife Dermody and Suzi Lyons)
1. Lyons S (2008) Community detoxiﬁ cation pilot scheme. 
Drugnet Ireland, (26): 18.
2. Health Research Board (2010) 2010 National Report 
(2009 data) to the EMCDDA by the Reitox National Focal 
Point. Ireland: new developments, trends and in-depth 
information on selected issues. Dublin: Health Research 
Board. www.drugsandalcohol.ie/14714
3. A copy of the protocol and pilot evaluation is available 
at: www.progressionroutes.ie/uploads/docs/Evaluation.
pdf
4. The Steering Group consists of: Chair, Mr Tony Dufﬁ n 
(voluntary organisations representative, Ana Liffey); Dr 
Brion Sweeney (National Drug Treatment Centre Board); 
Dr Austin O’Carroll (Safetynet); Dr Íde Delargy (ICGP); 
Dr Suzi Lyons (HRB); Dr Joanne Fenton (Access Team); 
Ms Irene Crawley (voluntary organisations representative, 
HOPE); Mr Brian Friel (Peter McVerry Trust); Mr Ruaidhri 
McAuliffe (UISCE Service Users Union); Ms Aoife 
Dermody (Progression Routes Initiative) Ms Caroline 
Gardner (Progression Routes Initiative); Dr Des Crowley 
(HSE); Advisor, Mr Joe Doyle (HSE).
5. Progression Routes (2011) Community Detoxiﬁ cation 
Protocols: methadone. Dublin: Progression Routes. 
Available at www.progressionroutes.ie
6. Progression Routes (2011) Community Detoxiﬁ cation 
Protocols: benzodiazepines. Progression Routes: Dublin. 
Available at www.progressionroutes.ie
Community detoxiﬁ cation (continued)
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 Quantitative evidence of a heroin drought
The Drug Treatment Centre Board (DTCB) laboratory 
provides a nationwide service to the HSE Addiction Services, 
hospitals, general practitioners, voluntary organisations, the 
Department of Education (juvenile detention centres), the 
Probation Service, the Courts Service, the Medical Council, 
an Bord Altranais and occupational health departments. The 
Laboratory is accredited by the Irish National Accreditation 
Board (INAB) to ISO/IEC 17025 standard (INAB scope 169T). 
The percentage of samples testing positive for drugs gives a 
quantitative measure of the extent of their use. With its large 
sample throughput, the DTCB laboratory is ideally placed to 
monitor trends in the prevalence of drugs in the drug-using 
population.
6-acetylmorphine (6-AM) is used as a marker for heroin use, 
being a unique metabolite only present when heroin has 
been taken. From 2005 to 2009, samples testing positive for 
6-AM increased signiﬁ cantly, reaching an average of 29% in 
2009. Samples testing positive for opiates followed a similar 
pattern. The data demonstrated a signiﬁ cant increase in the 
use of heroin in Ireland over this period. 
A HRB paper on trends in treated opiate use1 noted a 20% 
increase in the number of opiate cases presenting to drug 
treatment services between 2002 and 2007. In 2007 11,392 
cases were treated for opiate use (mainly heroin) and three 
out of ﬁ ve people entering treatment cited an opiate as their 
main problem substance. 
According to the European Monitoring Centre for Drugs 
and Drug Addiction (EMCDDA), heroin still accounts for the 
greatest share of morbidity and mortality related to drug use 
in Europe.2 A decline in heroin use and associated problems 
was observed in the late 1990s, however from 2003-04 
the trend became less clearly deﬁ ned. Our data showed 
increased use of heroin between 2005 and 2009.
According to the UN Ofﬁ ce on Drugs and Crime World drug 
report 2011, Ireland has the highest drug-related mortality 
rate in the EU and the third highest in the whole of Europe. 
The primary cause of poisoning deaths in Ireland was heroin 
and other opiates (such as methadone and codeine). 
Polysubstances were found in 61% of all deaths by 
poisoning in 2008 as recorded by the National Drug-Related 
Deaths Index.3 Heroin, methadone and other opiates 
(unspeciﬁ ed opiates and analgesics containing opiates) were 
implicated in 32.3%, 29.3% and 22.5% respectively of all 
cases. Benzodiazepines were found in 38.0% of all cases and 
played a major role in polysubstance deaths, being involved 
in more deaths by poisoning than any other substance in the 
period 1998–2008.
In November 2010 a heroin ‘drought’ was reported in the 
UK.4 The report stated that hospitals were treating a growing 
number of drug users who had overdosed on heroin mixed 
with other substances. Concerns were expressed that what 
was being sold as heroin appeared to be adulterated with 
a powerful sedative and mixed with a high percentage of 
bulking agents like talcum powder or paracetamol. 
This UK report was followed by anecdotal reports of a similar 
heroin drought in Ireland. A warning was issued to users 
on the website drugs.ie.5 The Irish Needle Exchange Forum 
website also warned of the dangers of overdose, lowered 
tolerance and other health risks.6 According to the INEF, the 
poor quality of the heroin available led some users to switch 
from smoking to injecting, and to use of 2.5ml needles 
to overcome the tendency of the contaminated heroin to 
congeal in 1ml needles, thus increasing overdose risk. 
Study of the percentages positive of 6-acetylmorphine(6-
AM) in samples tested over this period shows a very sudden 
decrease in positive samples in December 2010 (Figure 1), 
giving quantitative evidence of the extent of the drought in 
Ireland at this time, since heroin is the main drug of choice 
of the population being tested. This reduction in 6-AM 
positive samples is tracked closely by a similar decrease in 
opiate positive samples (as would be expected).
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Figure 1 Opiate and 6-acetylmorphine (6-AM) positive samples 2010–2011
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Looking at the data in 2011, it is clear that, while there has 
been some recovery in supply of heroin since January, there 
is still a signiﬁ cant reduction in the 6-AM positive samples. 
Only 18% of the samples tested in November 2011 were 
6-AM positive, as compared to 37% in January 2010. Opiate 
positives also decreased, from 39% to 28%.
Our data indicate that either the availability of heroin is 
signiﬁ cantly reduced currently or the heroin available in the 
market at this time is lower in strength than that normally 
available, thus giving rise to fewer positive samples.
In February 2011 three overdose deaths occurred in 
Kilkenny, followed by three deaths in Dublin. The overdoses 
were reportedly the result of batches of ‘high quality’ heroin 
coming into circulation following a heroin ‘drought’ over 
Christmas and the new year.7 However, in March 2011 fears 
were raised that the heroin involved in the six deaths had 
been mixed with benzodiazepines.8
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Figure 2 Benzodiazepine positive samples 2010–2011
A signiﬁ cant increase in benzodiazepine use has occurred 
since 2005. Benzodiazepine positive samples increased from 
51% in 2005 to an average of 56% in 2010. Benzodiazepine 
positive samples spiked in December 2010, coinciding 
with the heroin drought (Figure 2). There is an ongoing 
increase in benzodiazepine positive samples (averaging 58% 
currently). This may reﬂ ect market response to an ongoing 
reduction in heroin availability or strength by increased use 
of benzodiazepines as a substitute.
The extent to which this increase could be due to heroin 
being ‘cut’ or substituted with benzodiazepines is unknown. 
These drugs are also sold to a signiﬁ cant extent in the illicit 
drug market. In 2010 the Irish Medicines Board seized 
822,484 units of counterfeit medicinal products, of which 
153,483 units were sedatives, including diazepam, zopiclone 
and ﬂ urazepam.9 
Unfortunately, it is difﬁ cult to quantify the extent of the 
increase in use of benzodiazepines, as a large proportion of 
the drug-using population are prescribed benzodiazepines, 
and increased illicit use in this cohort will not necessarily be 
reﬂ ected in the ﬁ gures. 
There was also a temporary peak in cocaine use at the time 
of the heroin drought in December2010, when apparently 
it was being used as an alternative to heroin (Figure 3) but 
positive samples have now returned to the level seen prior to 
the heroin drought.
According to an article in Druglink,10 unpublished ﬁ gures 
from the UK Forensic Science Service showed that the 
average purity of street heroin there was at an all-time low of 
13.1% in January 2011 (from an average purity of 30–40%). 
Increased use of black market diazepam was feared to have 
been responsible for a number of deaths in Cardiff. Possible 
causes of the heroin drought cited included fungal blight 
of the poppy crop, recent law enforcement operations 
disrupting the supply network, stockpiling by wholesalers to 
increase the price or diversion of supply to an easily accessed 
and growing Russian market. If the reason for the drought 
is one of the last, it could have a more long-term impact on 
the situation. 
The ﬁ rst EMCDDA Trendspotter meeting in October 
2011 on ‘Recent shocks in the European heroin market: 
explanations and ramiﬁ cations’11 found that a small number 
of countries including Ireland experienced a severe shortage 
of heroin most heavily felt between November 2010 and 
March 2011. Divergent situations existed in Europe and 
the reasons for the drought were multifaceted. In areas 
where heroin drought was experienced drug users were 
reportedly increasing use of both alcohol and non-prescribed 
benzodiazepines to ﬁ ll the vacuum.
The heroin drought seems to have had an ongoing impact 
on heroin supply in Ireland as heroin use continues to 
be down on previous ﬁ gures. However, this has been 
counterbalanced by an increase in benzodiazepine use. The 
signiﬁ cant rise in benzodiazepine use is worrying considering 
their role in polysubstance deaths, although perhaps this 
may be mitigated by the corresponding decrease in heroin 
use which seems to have occurred. The effect of the heroin 
drought in terms of mortality among drug users will only 
evolve over time.
Evidence of heroin drought (continued)
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Figure 3 Cocaine positive samples 2010–2011
(Siobhán Stokes, Principal Biochemist, DTCB laboratory)
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Evidence of heroin drought (continued)
New drink driving limits and penalties 
in Ireland
The drink drive limit in Ireland was recently reduced and is 
now in line with European levels. The new Blood Alcohol 
Concentration (BAC) limit is 50 milligrams (mg) for all 
drivers, and 20mg for speciﬁ ed drivers, deﬁ ned as learner 
or newly qualiﬁ ed drivers (for a period of two years after 
passing their driving test) or professional drivers (of buses, 
goods vehicles and public service vehicles). 
A new penalty system has been introduced to deal with 
offences that come under the new limits. Under the previous 
system, all drink driving offences were dealt with in the 
courts and those who were convicted were automatically 
disqualiﬁ ed from driving. Under the new system, a driver 
who fails a preliminary breath test at the roadside will still 
be arrested and required to provide an evidential breath, 
blood, or urine specimen at a Garda station. However, if 
the driver’s BAC does not exceed 100mg and they are not 
already disqualiﬁ ed from holding a driving licence at the 
time of detection or have not availed of the administrative 
ﬁ xed penalty notice option in the preceding three years, he 
or she will be served with a ﬁ xed penalty notice (Table 1). 
A driver can only avail of the ﬁ xed penalty option once in a 
three-year period. 
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Table 1 Drink driving limits and penalties under the new system
BAC level Speciﬁ ed drivers (learner, newly 
qualiﬁ ed, and professional drivers)
All other drivers
20–80mg* €200 ﬁ ne
Disqualiﬁ cation from holding a driving 
licence for 3 months
50–80mg* €200 ﬁ ne
Three penalty points which will remain on a licence record 
for three years
Any driver accumulating 12 points in a three-year period will 
be disqualiﬁ ed from driving for a period of 6 months. 
80–100mg €400 ﬁ ne
Disqualiﬁ cation from holding a driving licence for 6 months 
*If a driver cannot produce their driving licence when required to undergo a preliminary breath test, the lower limit of 
20mg will apply until such time as the driver produces their licence.
Court proceedings will not be initiated if the driver pays the 
ﬁ xed charge and accepts the penalty. If a driver does not 
accept the ﬁ xed penalty notice and goes to court and is 
unsuccessful in appealing, the penalties are increased; for 
ﬁ rst offences where the BAC does not exceed 80mg a 
six-month disqualiﬁ cation period applies, while a one-year 
disqualiﬁ cation period applies for offences where the BAC is 
80–100mg. 
Where the BAC detected is above 100mg, or above 80mg 
for a speciﬁ ed person, where the person is not eligible to be 
served with a ﬁ xed penalty notice, or where payment has 
not been made in respect of a ﬁ xed penalty notice, the court 
penalties relating to disqualiﬁ cation from driving outlined 
in Table 2 apply on conviction. In addition, the court may 
apply a ﬁ ne up to of €5,000 and/or six months in prison. 
Table 2 Disqualiﬁ cation periods that apply to drink driving offences convicted in court
BAC level 1st offence 2nd offence
<80mg (speciﬁ ed drivers only) 6 months 1 year
80–100mg 1 year 2 years
101–150mg 2 years 4 years
151mg+ 3 years 6 years
Further information on the new drink driving limits may 
be obtained from the Road Safety Authority www.rsa.ie 
or from the Department of Transport, Tourism and Sport 
www.transport.ie. 
(Deirdre Mongan)
New drink driving limits (continued)
AAI conference addresses alcohol-
related harms
Alcohol Action Ireland held a conference titled ‘Alcohol: 
Where’s the harm?’ on 15 November in the Royal College of 
Physicians. The conference was opened by Róisín Shortall, 
Minister of State with responsibility for Primary Care at the 
Department of Health, who said that parental attitudes to 
drinking were sometimes ‘ambivalent’ and ‘irresponsible’. She 
also said that the ‘time was right for action to be taken’ and 
that she wanted to focus attention on minimum pricing and 
tougher enforcement of underage selling and distance selling 
of alcohol, such as phone and online ordering of alcohol.
Fiona Ryan, director of Alcohol Action Ireland, launched 
the results of a national survey commissioned by her 
organisation which looked at the harms and damage 
caused by other people’s drinking. The sample consisted 
of 1,001 adults aged 16 and over and interviews were 
conducted by telephone as part of a Behaviour and Attitudes 
Telebarometer survey. 
Almost six in 10 respondents stated that they had been 
affected by alcohol-related incidents in their community 
in the previous year as a result of someone else’s drinking; 
this included 45% who stated that they had gone out of 
their way to avoid drunk people or places where drinkers 
were known to hang out, 21% said that they had been 
kept awake at night or disturbed, 12% had been verbally 
abused and 8% had been threatened. Harms were more 
frequently experienced by men, younger people and those 
living in urban areas. Nine per cent reported that either they 
or a family member had been assaulted by a person under 
the inﬂ uence of alcohol, which corresponds to 318,000 of 
the total population aged 16 and over. However, only 45% 
of those who had personally been assaulted reported the 
assault to the police. 
In relation to property damage, 7% stated that their house 
or car had been damaged, 13% had had to clean up outside 
their house, and 5% had had to pay to repair damage to 
home, car or property as a result of someone else’s drinking. 
Ms Ryan said that, based on these results, the estimated cost 
to the country of damage, clean-up costs and repairs was 
€164.9 million.
Ann Hope outlined the Irish and international evidence in 
relation to the link between alcohol and crime and identiﬁ ed 
the factors most associated with alcohol-related violence as 
regular risky drinking, being male and being young. From 
a policy perspective, she said that we needed licensing laws 
with clear public health objectives, a review of outlet density 
and a ban on cheap promotions. Sean Byrne presented an 
analysis of the economic costs of alcohol-related crime in 
Ireland in 2010, which amounted to €1.8 billion. This ﬁ gure 
drugnet 
IRELAND
25
includes the costs of policing alcohol-related crime, the costs 
to the court, prison and probation systems and the costs in 
anticipation of crime. 
Superintendent Colette Quinn, director of the Garda 
Juvenile Diversion Programme, described how the 
programme is dealing with the issue of alcohol, while 
Sandra Coughlan described the evolution of the Club Cork 
project and the development of additional regional projects 
in the HSE South Region. Martine McKillop and Stevie 
Lavery discussed how Northern Ireland is tackling alcohol-
related crime. 
Clíona Saidléar of Rape Crisis Network Ireland highlighted 
the link between alcohol and sexual violence and said that 
alcohol consumption, especially drinking to intoxication, 
was a feature in a high proportion of rapes committed in 
Ireland. She also discussed the role of alcohol in Irish culture. 
She said that in Irish law and legal practice alcohol is not a 
mitigating factor in sexual offence cases, however, in Irish 
culture alcohol is often cited as a mitigating factor for so-
called ‘uncharacteristic’ behaviour, such as violence or rape 
committed while intoxicated. Sharon O’Halloran, director 
of Safe Ireland, spoke of the link between domestic violence 
and alcohol, as did Christine Toft of Alcohol Concern in the 
UK. There is a huge overlap between alcohol and domestic 
violence; perpetrators often use alcohol before or during the 
incident, while victims may use alcohol to numb the pain 
of the abuse. Thomas Bibby of MOVE (men overcoming 
violence) Ireland stressed the need for greater multi-agency 
collaboration as sexual/domestic violence and drug/alcohol 
use are overlapping issues. He concluded that by working 
together we can improve the way services are delivered, 
providing better protection to women and children.
Copies of all the presentations may be accessed on Alcohol 
Action Ireland’s website http://alcoholireland.ie/. 
(Deirdre Mongan)
AAI conference (continued)
Alcohol consumption and pregnancy: 
a retrospective cohort study
 This study estimated the prevalence of peri-conceptional 
alcohol consumption and the relationship between it and 
maternal characteristics and perinatal outcomes.1 This was 
a retrospective cohort study of 61,241 singleton births at a 
large Dublin maternity hospital in the period 2000–2007, 
based on antenatal, delivery, postnatal and neonatal 
records. Self-reported alcohol consumption at the booking 
visit (usually between 12 and 20 weeks gestation) was 
categorised as: never (lifetime abstainers), low (0–5 units per 
week), moderate (6–20 units per week) and high (more than 
20 units per week).
The numbers and proportions reporting each category of 
alcohol consumption were: abstainers (11,613, 19%), low 
or occasional drinkers (43,455, 70.9%), moderate drinkers 
(6,059, 9.9%), and high or heavy drinkers (114, 0.2%). 
The categories reporting any level of alcohol consumption 
accounted for 81% of the cohort. 
The proﬁ le of those who never drank alcohol indicates that 
23% were under 25 years old, 73% were married, 32% 
were housewives, 25% were unemployed, 57% were not 
Irish, 10% had private health care, 68% had had at least 
one previous pregnancy, 36% had not planned their current 
pregnancy, 23% had booked antenatal care after 20 weeks 
gestation, 18% smoked cigarettes, 1.5% had used illicit 
drugs at some point in their life and 21% had been referred 
for antenatal care by a social worker. 
The proﬁ le of low alcohol consumers indicates that 18% 
were under 25 years of age, 66% were married and 86% 
were Irish. Just over one third (34%) were in non-manual 
employment, while one quarter were professionals, managers 
or business owners. Twenty-eight per cent had private 
health care. Just under three-ﬁ fths (59%) had had at least 
one previous pregnancy and 34% had not planned their 
current pregnancy. Only a small minority (11%) had booked 
antenatal care after 20 weeks gestation. Twenty-three per cent 
smoked during their current pregnancy and less than 1% had 
used illicit drugs at some point in their life. Twelve per cent 
had been referred for antenatal care by a social worker.
The proﬁ les of low and moderate alcohol consumers were 
similar in that these groups were marginally older than those 
who had never consumed alcohol. The occasional drinkers 
were less likely to smoke than the moderate drinkers, and 
more likely to have had a previous pregnancy and to have 
planned this pregnancy. The moderate drinkers were more 
likely than the occasional drinkers to be single, to smoke 
cigarettes and to have private health insurance.
The proﬁ le of heavy drinkers was very different to that of 
the other three groups: they were very young (45% of the 
group were under 25 years of age), just under 80% were 
single, one third were unemployed, 90% were Irish, only 
3.5% had private health care, 68% were pregnant for the 
ﬁ rst time, 75% had not planned their current pregnancy, 
70% smoked during their pregnancy, 9% had used illicit 
drugs at some point in their life and 40% had been referred 
by a social worker. 
The proﬁ les of those who consumed alcohol were compared 
to the proﬁ le of the group who never drank alcohol. Factors 
associated with moderate alcohol consumption included 
being in employment, being of Irish nationality, having 
private health care and smoking. Factors associated with high 
consumption included maternal age less than 25 years and 
illicit drug use. High alcohol consumption was also associated 
with very preterm birth (less than 32 weeks gestation) even 
after controlling for socio-demographic factors. 
Only three cases of Fetal Alcohol Syndrome (FAS) were 
recorded (0.05 per 1,000 total births), one each in the low, 
moderate and high consumption groups. The fact that cases 
of FAS occurred in the low and moderate consumption 
groups may be explained by under-reporting of alcohol 
consumption by pregnant women, as FAS does not normally 
occur in the infants of low and moderate users. 
There is a need to ensure a consistent and accurate approach 
to recording alcohol intake at the ﬁ rst antenatal visit. Other 
countries include measures of binge drinking at this visit 
and, given that binge drinking is very common in Ireland, 
this may be an important measure to identify risk of and 
prevent negative outcomes. It is clear that some pregnant 
women currently under-report their alcohol consumption. 
This and other studies completed from routinely collected 
patient data at this large Dublin maternity hospital 
demonstrate the value of analysing such data to identify 
issues and improve current practice. 
(Jean Long)
1. Mullally A, Cleary BJ, Barry J, Fahey T and Murphy DJ 
(2011) Prevalence, predictors and perinatal outcomes of 
peri-conceptional alcohol exposure: retrospective cohort 
study in an urban obstetric population in Ireland. BMC 
Pregnancy and Childbirth, 11: 27 (11 April 2011).
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Children’s exposure to risks from 
parental drinking
A recent report, Hidden realities – children’s exposure to risks 
from parental drinking in Ireland,1 examined the impact 
of hazardous and harmful use of alcohol on children, in 
particular in the north west of Ireland. This was done by 
analysing general population surveys and agency records, 
and interviewing family support services.
Main ﬁ ndings
General population survey
The National Drinking Surveys of 2006 and 2010 were 
combined for this analysis, which gave a total sample of 
2,011 adults aged 18 years and over. Over half of all adult 
drinkers who had children living in their household engaged 
in regular hazardous drinking (deﬁ ned as consuming the 
equivalent of four pints of beer or one bottle of wine or 
seven spirits in one sitting at least once a month). When 
these ﬁ gures are applied to the national population, 
approximately 271,000 children aged under 15 years are 
exposed to risk from hazardous drinking by parents. One 
in seven (14%) adults reported that they had experienced 
family problems as a result of someone else’s drinking, 
which equates to approximately 449,000 families negatively 
affected by alcohol. Family problems were reported more 
often by women, those under 35 years and those in the 
lower social class.
The 2010 survey also contained questions that measured 
children's exposure to neglect or abuse because of someone 
else’s drinking. These questions were asked of respondents 
who had parental or guardianship responsibility. One in ten 
adults reported that children for whom they had parental 
responsibility had, as a result of someone else’s drinking, 
experienced one or more of the following harms: verbal 
abuse, physical abuse, witnessing violence in the home, or 
being left in unsafe situations. Harms were reported more 
often by parents who engaged in regular hazardous drinking 
and by those in the lower social class. 
National Drug Treatment Reporting System
For the period 2007–2009, 3,234 cases living in the north 
west entered treatment for problem substance use, of 
whom 2,417 reported that alcohol was their only problem 
substance. Of these 2,417 cases, 29% were living in 
households with children.
Donegal community alcohol survey
A community alcohol survey was completed by 554 
participants across six communities in Co Donegal. The 
level of awareness of risk to children as a result of someone 
else’s drinking varied from 12% to 57%. In ﬁ ve of the six 
communities, awareness of children being verbally abused 
as a result of someone else’s drinking was the highest ranked 
risk; this was followed by awareness of children being left in 
an unsupervised or unsafe situation.
National child protection data results
National data reported by the HSE for 2006–2008 showed 
an increase in the number of reports received by social work 
departments in relation to child protection issues, from 
21,040 reports in 2006 to 24,688 in 2008. The National 
Child Care minimum dataset for 2008 recorded the 
principal reason reported for child welfare concerns. 
For 15% the principal reason was a family member abusing 
drugs/alcohol, and for 3% the principal reason was the 
child abusing drugs. In Co Donegal 24% of child welfare 
concerns were due to a family member abusing drugs/
alcohol, while the corresponding ﬁ gure for Sligo/Leitrim/
West Cavan was 16%.
RAISE data
RAISE is a case management IT system used by social 
workers. Analysis of these data revealed that alcohol abuse 
was mentioned in over a third (36%) of child protection 
cases in Co Donegal.
Focus groups with frontline staff working in family services
Focus groups were conducted in Donegal and Sligo and 
included social workers, youth workers, addiction counsellors 
and community support services (NGOs). For most of the 
frontline staff an intervention with families regarding alcohol 
problems only occurred when the problems had reached 
a crisis point. Some of the burdens borne by children as 
a result of parental alcohol abuse included role reversal, 
whereby children took responsibility for household tasks and 
caring for their parents, and keeping the alcohol problem 
secret. These burdens can have considerable negative effects 
on a child’s schooling and social life. 
Conclusion
The results of this study indicate that children in Ireland and 
the North West are exposed to considerable risks as a result 
of someone else’s drinking and there is a need to reduce 
the level of hazardous drinking among adults in Ireland. 
The author concludes that ‘effective family support services 
are needed that actively address family alcohol problems 
through prevention and early intervention, as well as the 
more specialised treatment services as part of an integrated 
strategy to tackle family alcohol problems, which impact on 
the welfare of children’. 
(Deirdre Mongan) 
 1. Hope A (2011) Hidden realities: children’s exposure to risks 
from parental drinking in Ireland. Letterkenny: North West 
Alcohol Forum Ltd. www.drugsandalcohol.ie/16250
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A family affair? Seminar on parental 
substance misuse
Minister of State Róisín Shortall gave the opening address 
at the seminar ‘Parental substance misuse: addressing its 
impact on children’ on 18 October.1 The event was jointly 
hosted by the National Advisory Committee on Drugs 
(NACD), the Social Inclusion Unit of the Health Service 
Executive and Alcohol Action Ireland. 
Minister Shortall congratulated the authors of the report, 
commenting on its timely focus on young people who were 
at risk because of their parents’ substance misuse. ‘The real 
challenge is to break this cycle. The fact that substance 
misuse in one generation can have impacts that cascade into 
the lives of those following illustrates the level of importance 
that we must place on targeted measures aimed at breaking 
the cycle and safeguarding the next generation.’ As well as 
acknowledging the substance misuser’s need to focus on 
recovery and a life without drugs, the Minister also spoke 
about recognising children in their own right and consulting 
them on issues that affect their lives. She also spoke about 
problem alcohol use as an important public health issue, 
the need to reduce the amount of alcohol consumed in 
the country, and the development of a National Substance 
Misuse Strategy.
Dr Justine Horgan, senior researcher at the NACD and author 
of the report Parental substance misuse: addressing its impact 
on children,2 presented some of the key messages from her 
review of the literature (see page 28 for a summary of that 
report).
This was followed by some lively round table discussions 
where the seminar participants were asked to identify 
important themes around ‘what works in providing support, 
and the challenges in providing support, to children 
living with parental substance misuse’. A summary of the 
discussions will be provided by the NACD but a ﬂ avour of 
the responses is given here. Some of the themes identiﬁ ed 
for what works were early intervention, interagency work, 
listening to children and speciﬁ c training in addiction. Some 
of the themes around challenges were: getting the child’s 
voice heard, issues of fathers, funding and poor perception 
of services by the families.
Norah Gibbons (chair of Alcohol Action Ireland and director 
of advocacy at Barnardos) spoke about prioritising children 
in policy and practice.3 She spoke eloquently about the very 
real impact of parental substance misuse on children. In 
some cases the child has to become ‘the parent’, looking 
after younger siblings, worrying about the adult parent, 
children who were often ‘leading lives of quiet desperation’. 
Finally, she supported the need for a constitutional 
amendment to ensure children’s rights in this country.4
There were four parallel workshops in the afternoon: 
Learning for service responses – Ballyfermot Star;5 North 
West Alcohol Forum – The Families Matter Programme;6 
Building knowledge and skills for better outcomes for 
children – the role of Children First;7 and Hidden Harm 
Action Plan, a partnership approach for better outcomes for 
children living with parental drug and alcohol misuse.8 
Paul Barron, assistant secretary at the Department of 
Health, chaired the ﬁ nal session. Another of the other key 
speakers was Mary Forrest, clinical director of CrossCare 
Teen Counselling, who spoke particularly about teenagers. 
She outlined some of the changes she had seen in her 
work, remarking that although teenagers now were more 
willing to seek counselling, funding for services was being 
reduced. She said that there was now greater awareness 
of the negative impact of parental substance misuse on 
children, which was a positive sign, and she welcomed 
the development of the new combined substance misuse 
strategy.
Phil Garland, assistant national director of HSE Children and 
Family Services, also spoke in the afternoon. He welcomed 
the seminar as an opportunity for policy makers and front 
line staff to consider the issues around this problem. He 
stated that there needed to be collaboration on all levels, 
between agencies, to support children whose parents have a 
substance misuse problem ‘and to increase the effectiveness 
of frontline child protection and addiction services with 
collaborative interventions based on measurable change 
outcomes’.
Frances Fitzgerald TD, Minster for Children and Youth Affairs, 
gave the closing address at the seminar. She spoke about 
the importance of interagency work for all those involved 
with children at national, regional and local level and how 
the new Department of Children will play a key role in 
supporting this process.
(Suzi Lyons)
1. See the NACD report on the conference at 
http://www.nacd.ie/publications/index.html
2. Horgan J (2011) Parental substance misuse: addressing 
its impact on children. A review of the literature. 
Dublin: NACD. Available on-line only, at 
http://www.nacd.ie/publications/index.html
3. A transcript of Ms Gibbons’s presentation is available at 
www.nacd.ie/publications/prioritising_children.pdf
4. For further information see www.barnardos.ie/what-we-
do/campaign-and-lobby/childrens-rights.html
5. www.nacd.ie/publications/a_family_affair.html
6. www.nacd.ie/publications/strengthening_families_
programme.html
7. www.nacd.ie/publications/knowledge_and_skills.html
8. www.nacd.ie/publications/hidden_harm.html
Pictured at the NACD conference (l to r): Fiona Ryan, 
Director of Alcohol Action Ireland; Dr Des Corrigan, 
NACD; Minister of State Róisín Shortall; and Dr Justine 
Horgan, NACD (Photo: Conor Healy) 
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Prioritising children in drug policy and 
practice
The needs of children of drug-using parents are attracting 
attention from policy makers and service providers both here 
in Ireland and in Europe. 
Barnardos and the Family Support Agency
On 10 October 2011 Barnardos and the FSA launched 
Parenting positively – coping with a parent’s problem drug 
or alcohol use, a new resource for children, teenagers and 
their parents to support them in understanding and dealing 
with difﬁ culties that can result from a parent’s problem 
drug or alcohol use: it not only gives parents an insight as 
to how their behaviour, or that of their partners, is affecting 
the child, but also helps the child to understand what is 
happening and what they can do to help themselves. 
The resource comprises three booklets – one for children 
aged 6–12, one for parents of children aged 6–12, and 
one for parents of teenagers. The booklets are written in 
a question and answer format, with contributions from 
children and parents who have experienced the impact of 
alcohol and drugs on their family. Teenagers are catered 
for with an online resource available at www.barnardos.
ie/teenhelp. The Parenting Positively series of booklets, 
of which this resource is the latest, are available free to 
download from www.barnardos.ie or www.fsa.ie .  
National Advisory Committee on Drugs, Health Service 
Executive and Alcohol Action Ireland
On 18 October 2011 the NACD, HSE and Alcohol Action 
Ireland hosted a one-day seminar, attended by policy makers 
and service providers, at which a report, Parental substance 
misuse: addressing its impact on children, was launched. 
Having reviewed all the major international research on the 
impact of parental substance misuse on children, author 
Dr Justine Horgan, senior researcher with the NACD, 
reports that children of substance misusers are more likely 
to experience problems with mental health, social skills, 
academic achievement and substance use. The report is 
available for download at www.nacd.ie .
Horgan identiﬁ es ﬁ ve priority areas for policy makers, service 
providers and researchers to consider:
1. Consequences of parental substance misuse for child 
development: substance misuse during pregnancy can 
have harmful effects on the baby. 
2. Consequences for parenting and family life: the stress 
owing to parental substance misuse combined with 
the increased likelihood of the child being in care and/
or suffering homelessness, results in these children 
being at a high risk of emotional isolation and/or social 
marginalisation.
3. Impact on child outcomes: for many affected children, 
the effect continues into their adult lives; for some, the 
impact can be multifaceted and persist not only into 
adult life but even into the lives of the next generation.
4. Response to parental substance misuse: more integrated 
working between addiction services, children’s services 
and medical professionals is needed to help reduce the 
negative impact of parental drug and alcohol misuse on 
children and the wider family. 
5. Future research and data needs: ﬁ ve research areas 
are identiﬁ ed that would help to ﬁ ll gaps in Ireland’s 
research, statistics and information regarding children of 
parents who misuse drugs.
Key recommendations include:
 ■ Additional research and data collection to properly 
estimate the number of children whose parents have 
substance misuse problems.
 ■ The HSE Children First guidelines to be used by all 
services and organisations working regularly with 
children who experience parental substance misuse and 
with their parents.
 ■ Assess the extent to which adult alcohol and drug 
treatment services are supporting parenting and liaise 
with child support and other relevant services.
 ■ Assess the extent to which professional education 
and training in areas such as youth work, psychology, 
addiction support, guidance, counselling and childcare 
can address children affected by parental substance 
misuse.
 ■ Educate women on the adverse effects of consuming 
alcohol and drugs during pregnancy and train medical 
professionals so that they can raise awareness among 
their patients of the risks of consuming these substances.
 ■ Consider appropriate interventions and ways of working 
for primary health care staff who are involved in the early 
stages of children’s lives such as public health nurses, GPs 
and community mothers.
Speaking at the seminar, Norah Gibbons, chair of Alcohol 
Action Ireland and director of advocacy at Barnardos, called 
for the following:
1. Invest in prevention and early intervention services by 
increasing collaboration between organisations and 
functions, and increasing awareness and understanding 
among service providers of the needs of children and 
families damaged by parental alcohol problems. Develop 
joint local protocols between addiction services, health 
and social services, adult and children’s services, in both 
the voluntary and statutory sectors. 
2. Make services more holistic, i.e. a ‘whole family’ 
approach, such as that provided by Northern Ireland’s 
‘Hidden Harm Action Plan’ for children living with 
parental substance misuse. 
3. Provide services and supports directly to children, for 
example through self-referral services, helplines, in-
school counselling, therapeutic support or emergency 
accommodation.
4. Ensure organisations are clear about their responsibilities 
under Children First by putting the guidelines on a 
legislative basis. Drug and alcohol services have a crucial 
role to play here, in terms of identifying parents who 
are need of support with their parenting and caring 
responsibilities and providing appropriate treatment, 
guidance and referral.
5. Amend the Constitution to enshrine children’s rights. 
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What will you do differently/how will you act to prioritise 
children in your organisation?
What does your organisation do to ensure that children 
are seen and heard?
What will your organisation do differently?
Norah Gibbons
European Monitoring Centre for Drugs and Drug 
Addiction
Earlier this year the EMCDDA invited the national focal 
points in each of the 27 member states of the EU to report 
on drug-using parents and their children within their country 
– the current situation and the risks and harms, the 
legislative and policy framework, and the nature of 
responses. A summary report is expected to be published 
during 2012. 
(Brigid Pike)
Prioritising children in drug policy and practice (continued)
 Impact of legislation to control head 
shops
The Criminal Justice (Psychoactive Substances) Act 2010 
was implemented in response to the emergence of ‘head 
shops’ selling ‘legal highs’. After the Act came into force, the 
vast majority of such shops were closed down.
A number of academic articles have questioned the rationale 
behind the recent legislative approaches to controlling the 
legal high phenomenon. Reuter, in a review of international 
responses to new psychoactive substances, is extremely 
critical of the approach taken in Ireland.1 In criticising the 
regulatory impact analysis conducted by the Department of 
Justice and Equality,2 which included a cost-beneﬁ t analysis 
of the proposed legislation, Reuter states that the approach 
adopted was ‘of limited conceptual sophistication’ and 
ultimately naïve:
Consider for example Ireland, which has been active 
in the ﬁ eld. It has published an analysis of regulatory 
options for head shops, which are prominent there. 
The assessment makes no mention of any potential 
adverse effects of prohibition. It identiﬁ es the 
dangers of not regulating and the potential gross 
gains of the regulatory options. The only negative 
aspects of regulation that are given any attention 
are the costs of operating the regulation. It is naïve 
compared to, for example, environmental regulatory 
analysis, which requires much more careful balancing 
of costs and beneﬁ ts of each option. (p. 7) 
In a similar vein, Ryall and Butler set the controversy over 
head shops in Ireland and the resulting legislation within 
the framework provided by the sociological concept 
of ‘moral panic’.3 They describe this as a formulation 
of social policy whereby, in this instance, ‘the negative 
societal consequences of psychoactive drug use tend to be 
exaggerated – by the media and a range of other “moral 
entrepreneurs” – thereby serving to legitimate extreme 
policy responses which, paradoxically, may amplify the 
very deviance they were intended to curtail’ (p. 304). 
‘Based on semi-structured interviews with some of the main 
stakeholders in this process and set against a background of 
saturation media coverage of this phenomenon, this article 
presents and assesses competing perspectives on the head 
shop issue’ (p. 303).
The authors suggest that, ‘from a conventional drug-
control perspective, recent legislative measures in Ireland 
may be seen as representing effective cross-cutting activity 
between the health and criminal justice sectors. From a harm 
reduction perspective, however, this policy response may be 
seen as an example of moral panic in that media portrayals 
greatly exaggerated the ill effects of head shop products, in 
the process stoking public anger rather than encouraging 
rational debate’ (p. 303). Although the authors acknowledge 
‘a degree of sophistication on the part of all those 
interviewed’ (p. 310), including head shop owners, users, 
law enforcement personnel, policy advisors and the minister 
responsible for the drug strategy at the time, ultimately they 
conclude that ‘the great Irish head shop controversy ended 
in a clear victory for traditional “war on drugs” values’ (p. 
310).
The National Advisory Committee on Drugs published 
a study on new psychoactive substances and the outlets 
supplying them.4 The review, conducted between May 
and August 2010, sought to assess the availability and 
accessibility of new psychoactive substances in retail outlets 
throughout Ireland and online. With regard to the impact of 
new legislative measures, one of the conclusions reached by 
the authors was that ‘habitual drug users who were attracted 
by the legality and easy availability of head shop products 
are likely to return to “traditional” illegal substances’ (p. 
79). This view may be borne out by results of the fourth all-
Ireland general population drug prevalence survey showing 
a fall in ecstasy use in the last year, which may be partly 
explained by the proportion of young people reporting the 
use of new psychoactive substances sold in head shops and 
online (see article pages 6–7). 
(Johnny Connolly)
1. Reuter P (2011) Options for regulating new psychoactive 
drugs: a review of recent experiences. London: UK Drug 
Policy Commission.
2. Department of Justice and Equality (2010) Criminal Justice 
(Psychoactive Substances) Bill 2010: regulatory impact 
analysis. Dublin: Department of Justice and Equality.
3. Ryall G and Butler S (2011) The great Irish head shop 
controversy. Drugs: education, prevention and policy, 
18(4): 303–311.
4. Kelleher C, Christie R et al. (2011) An overview of new 
psychoactive substances and the outlets supplying them. 
Dublin: National Advisory Committee on Drugs. (See 
also Long J and Connolly J (2011) Report on new 
psychoactive substances and the outlets supplying them. 
Drugnet Ireland, (39): 9.)
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 Drug tests in Irish prisons
Information on drug testing in prisons in 2010 was obtained 
from the Irish Prison Service. These data indicate that more 
than 22,500 voluntary tests were carried out in 2010 to 
monitor drug use and responses to treatment. The tests 
included those carried out on people who were classiﬁ ed 
as inmates, and excluded committals. It may be assumed 
therefore that the positive test results relate to drugs or 
alcohol consumed inside the prison. 
The results indicate that a large proportion of drug users 
in treatment are opiate dependent and are in receipt of 
prescribed methadone. The numbers of positive tests 
for benzodiazepines indicates that benzodiazepines are 
prescribed for a signiﬁ cant minority of prisoners attending 
drug treatment, or that these prisoners are obtaining 
benzodiazepines through unregulated sources. The common 
illicit drug metabolites detected indicate use of cannabis 
and opiates in prison (Table 1). Cocaine, amphetamines 
and alcohol were detected in a very small number of tests, 
indicating that these drugs are rarely used in the prison 
environment. 
The proﬁ le of positive cannabis, opiate and benzodiazepine 
tests indicates use of these drugs among prisoners tested in 
Mountjoy Main prison. A sizeable number of inmates tested 
positive for benzodiazepines in the Dóchas Centre and 
Limerick prison. There is a sizeable amount of cannabis use 
at Loughan House and Mountjoy Main. There is a small but 
notable amount of benzodiazepine use at Castlerea prison, 
Cloverhill prison, Cork prison, Portlaoise prison, Loughan 
House, and the Midlands prison. There are small but notable 
amounts of opiate use at Portlaoise and the Midlands Prisons. 
(Jean Long)
Table 1 Number of drug tests, and number (%) of positive tests, by prison and by drug type, 2010
Prison No. of 
tests*
Alcohol Amphet-
amines
Benzo-
diazepines
Cocaine Methadone Opiates Cannabis
n (%) n (%) n (%) n (%) n (%) n (%) n (%)
Mountjoy Main 5266 20 (0.4) 2 (0.0) 2301 (43.7) 24 (0.5) 3864 (73.4) 2308 (43.8) 2011 (38.2)
Mountjoy Medical Unit 2871 9 (0.3) 0 (0.0) 245 (8.5) 2 (0.1) 1372 (47.8) 318 (11.1) 273 (9.5)
Dóchas Centre 
(Female) 
1768 9 (0.5) 2 (0.1) 959 (54.2) 25 (1.4) 1610 (91.1) 296 (16.7) 271 (15.3)
Training Unit 2270 4 (0.2) 3 (0.1) 19 (0.8) 3 (0.1) 3 (0.1) 33 (1.5) 24 (1.1)
Wheatﬁ eld 3499 28 (0.8) 2 (0.1) 695 (19.9) 0 (0.0) 2936 (83.9) 546 (15.6) 333 (9.5)
Cloverhill 1868 24 (1.3) 2 (0.1) 445 (23.8) 48 (2.6) 1350 (72.3) 309 (16.5) 203 (10.9)
St Patrick’s Institution 295 1 (0.3) 0 (0.0) 33 (11.2) 0 (0.0) 40 (13.6) 11 (3.7) 38 (12.9)
Castlerea 118 5 (4.2) 0 (0.0) 40 (33.9) 1 (0.8) 20 (16.9) 23 (19.5) 28 (23.7)
Loughan House 218 3  (1.4) 4 (1.8) 50 (22.9) 1 (0.5) 0 (0.0) 29 (13.3) 84 (38.5)
Shelton Abbey 384 20 (5.2) 3 (0.8) 25 (6.5) 8 (2.1) 0 (0.0) 10 (2.6) 61 (15.9)
Limerick 
(Male and Female)
793 21 (2.6) 5 (0.6) 309 (39.0) 5 (0.6) 633 (79.8) 142 (17.9) 125 (15.8)
Cork 67 4 (6.0) 2 (3.0) 16 (23.9) 0  (0.0) 11 (16.4) 3 (4.5) 11 (16.4)
Midlands 2756 20 (0.7) 10 (0.4) 807 (29.3) 7 (0.3) 2563 (93.0) 818 (29.7) 412 (14.9)
Portlaoise 332 4 (1.2) 0 (0.0) 83 (25.0) 0 (0.0) 214 (64.5) 75 (22.6) 57 (17.2)
Arbour Hill 8 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
*Results exclude all committals.
Source: Irish Prison Service, unpublished data, 2011
 Neuroscience and addiction recovery – 
NEAR conference
The ﬁ rst international NEAR conference took place in 
Wicklow over three days from 10 November 2011. There 
were three objectives:
 ■ to introduce delegates to Irish and international experts 
in the ﬁ eld of addiction;
 ■ to explore the latest neurological developments on 
potential causes and treatments;
 ■ to educate delegates about the latest evidence based 
recovery practices and their application.
The multi-disciplinary audience was composed primarily 
of counsellors, psychotherapists and other practitioners. 
Presentations explored issues arising from a range of 
addictions such as gambling, food, sex, and videogames, as 
well as alcohol and drugs. 
Some keynote speakers focused the neuroscience of 
addiction. For example, Dr Shelly Uram showed how 
psychological trauma can impact the brain and subsequent 
behaviour. She described how the effects of trauma are 
Contributors to the NEAR conference: Paddy Creedon, 
Brendan Murphy and Oisin McConville
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 ACAMH youth mental health conference
The Association for Child and Adolescent Mental Health special 
interest group, Youth Mental Health, held its ﬁ rst national 
research conference, Emerging evidence on youth mental 
health: multi-disciplinary perspectives, on 14 October 2011. 
The morning session focused on the rights of the child, 
with a talk by Emily Logan, Ombudsman for Children, and 
the launch of the International Declaration on Youth Mental 
Health, which sets out a range of measurable targets to be 
achieved over a 10-year period.1
Research on recognising mental health problems and on 
working towards solutions was then presented. A number of 
speakers quoted from Kessler and colleagues,2 whose study 
found that half of all cases of mental illness start by age 14 
years and three quarters by age 24 years. This key message 
underlined the importance of understanding and tackling 
mental health issues among young people.
The ﬁ nal session of the day centred on substance use among 
young people. Dr Bobby Smyth outlined a descriptive 
study of adolescents assessed at the Drug Treatment Centre 
Board.3 He highlighted the multiple and complex needs of 
teenagers who abused opiates, and concluded that services 
will require a broad range of interventions and effective 
interagency co-operation in order to meet these needs. 
Details of a recently published study on the outcomes for 
heroin-dependent adolescents were also provided.4 Professor 
Walter Cullen closed this session with a presentation about 
the role of community-based practice for mental and 
substance use disorders.5
The following services presented information about their 
work at the conference:
 ■ Jigsaw: a network of projects working with communities 
to better support young people’s mental health 
www.jigsaw.ie 
 ■ Working Things Out: a therapeutic resource for 
adolescents dealing mental health problems 
www.workingthingsout.ie
 ■ Inspire Ireland: which manages http://ie.reachout.com, 
an online service to help young people aged 16–25 get 
through tough times.
(Mary Dunne)
1. Buckley S, Canon M, Chambers D, Coughlan H, 
Duffy M, Gavin B et al. (2011) International 
Declaration on Youth Mental Health. Dublin: 
Association for Child and Adolescent Mental Health. 
www.drugsandalcohol.ie/16297 
2. Kessler RC, Berglund P, Dernler O, Jin R, Merikangas KR 
and Walters EE (2005) Lifetime prevalence and age-of-
onset distributions of DSM-IV disorders in the National 
Comorbidity Survey Replication, Archives of General 
Psychiatry, 62(6): 593–602. http://archpsyc.ama-assn.
org/cgi/content/abstract/62/6/593 
3. Fagan J, Naughton L and Smyth BP (2008) Opiate-
dependent adolescents in Ireland: a descriptive study at 
treatment entry. Irish Journal of Psychological Medicine. 
25(2): 46–51. www.drugsandalcohol.ie/12407 
stored in the brain’s survival areas implicated in ﬂ ight, 
ﬁ ght or freeze (shut-down or depressed) responses. 
Therapies such as EMDR (Eye movement desensitization 
and reprocessing) may be required to reach these ancient 
‘unconscious’ brain areas before ‘talking therapies’ are 
of use. She also suggested that recovery goes beyond 
stopping using addictive substances or behaviours, and 
means recovering one’s underlying true nature, which can 
be helped through processes such as 12-step. (To view 
videos on this topic by Dr Uram visit 
www.youtube.com/watch?v=6926eENqzwg.)
In another keynote address, Dr Carlton Erickson described 
addiction as a chronic, relapsing brain disease causing 
out-of-control behaviour. Drugs (including alcohol) are 
associated with speciﬁ c neurotransmitters (chemicals which 
allow the transmission of signals from one brain neuron to 
the next). It is assumed that for some people genetics, drug 
use and, possibly, environmental issues lead to dysregulation 
of the neurotransmitter system leading to compulsive use. 
People may get better through various types of treatment, 
such as psychosocial therapies, which ‘push back’ this 
system towards normal function. (For more information visit 
the University of Texas Addiction Science Research and 
Education Center at www.utexas.edu/research/asrec/.) 
Workshop sessions of 90 minutes gave presenters ample 
time to illustrate and discuss treatment topics such as 
mindfulness, group analytic psychotherapy, experiential 
therapies, oxygen therapy, and EMDR. Wider issues, such 
as the doctors’ role in addiction practice, dual diagnosis, 
including families in recovery, and the development of Irish 
drug and alcohol policy, were also included.
In one of these sessions, Brendan Murphy and Paul Goff 
spoke about the development of the alcohol and substance 
abuse prevention (ASAP) programme in the Gaelic Athletic 
Association (GAA), which helps clubs prevent and respond 
to problems. A new brief intervention training programme 
based on the SAOR model1 has been introduced for coaches. 
They are taught to Support, Ask and assess, Offer assistance 
and Refer players with substance-related issues for help. This 
intervention has the potential to reach large numbers of 
amateur sportsmen, who have reported high rates of alcohol 
consumption and alcohol-related harm.2
For more information about the conference programme 
and speakers visit the Toranﬁ eld House conference website 
www.nearconference.com. The 2012 conference is 
scheduled to take place between 8–10 November. 
(Mary Dunne)
1. O’Shea J and Goff P (2011) SAOR model. Screening and 
brief interventions for problem alcohol use in the emergency 
department & acute care settings. Waterford: Health 
Service Executive. www.drugsandalcohol.ie/15791 
2. O’Farrell A, Allwright S, Kenny S, Roddy G and 
Eldin N (2010) Alcohol use among amateur 
sportsmen in Ireland. BMC Research Notes. 3:313. 
www.drugsandalcohol.ie/14227 
NEAR conference (continued)
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 MQI annual review 2010 
The Merchants Quay Ireland (MQI) annual review for 2010 
was launched on 30 September 2011 by the Minister of 
State at the Department of Health, Róisín Shortall TD.1 
2010 saw the development of a number of important new 
initiatives at MQI. These initiatives are the Extended Day 
Service developed in association with Focus Ireland, New 
Communities Support Service, Midlands Traveller Speciﬁ c 
Drugs Project, Aftercare Housing in conjunction with 
Respond Housing Association, Drug Free Day Programme 
and Easy Access Education for Homeless People 
The review also provides additional information that is not 
fully reﬂ ected in the treatment ﬁ gures recorded by the 
National Drug Treatment Reporting System (NDTRS). 
MQI’s needle-exchange service recorded approximately 
25,000 client visits in 2010, a 20% decrease on 2009 ﬁ gures. 
The report highlights a continuing high level of demand for 
homeless services, with 57,840 meals provided in 2010. The 
number of health care interventions provided increased by 
15% to 3,685 in 2010.
In 2010 MQI successfully tendered to provide the national 
prison-based addiction counselling service to 13 prisons. In 
excess of 13,000 counselling hours were provided during 
2010. This service is provided by 23 counsellors, each with 
an average caseload of 550 prisoners.
MQI in association with the Midland Regional Drugs 
Task Force administers the Midlands Family Support and 
Community Harm Reduction Service, providing outreach 
and working with families of those actively using drugs in 
that task force region. The family support service provided 
services to 237 new clients across the region during 2010. 
The harm reduction service provided needle-exchange 
services to an average of 124 clients each month during 
2010. 
The services offered by MQI and the numbers of people 
accessing them in 2010 are shown below.
Service Type of intervention No. of participants Outcomes
Needle-exchange and 
health-promotion 
services
Promotes safer injecting techniques 
HIV and hepatitis prevention
Safe sex advice
Information on overdose
Early referral to drug treatment 
services
4308 used needle-
exchange services, of 
whom 575 were new 
clients
1,617 safer injecting 
workshops
Stabilisation services Methadone substitution 
Supportive day programmes
Gateway programme
Counseling
19
78 (monthly average)
Settlement service Assists service users to access interim 
and long-term accommodation
74 (quarterly average) 45 clients were resettled.
Integration 
programmes
Access to transitional accommodation 
Ballymount House
Group and one-to-one therapeutic 
sessions
3 (annual average)
Training and work 
programmes
FÁS Community Employment scheme 90 Of the 26 who completed 
FÁS placements at 
Merchants Quay, 6 secured 
permanent employment, 2 
moved to further education.
High Park 17-week, drug-free residential 
programme including individual 
counseling, group therapy, 
educational groups, work assignments 
and recreational activities
62 (of whom 13 
were admitted for 
detoxiﬁ cation)
10 clients completed detox 
St Francis Farm Therapeutic facility offering a 
6–12-month programme.
34 11 clients completed three 
months or more
(Vivion McGuire)
1. Merchants Quay Ireland (2011) Annual review 2010. 
Dublin: MQI. Available at www.mqi.ie 
4.  Smyth BP, Fagan J and Kernan K (2012) Outcome of 
heroin-dependent adolescents presenting for opiate 
substitution treatment. Journal of Substance Abuse 
Treatment. 42(1):35–44. www.drugsandalcohol.ie/15964 
5. Cullen W, Broderick N, Connolly D and Meagher D 
(2011) What is the role of general practice in 
addressing youth mental health? A discussion paper. 
Irish Journal of Medical Science, Early online. 
www.drugsandalcohol.ie/16025
ACAMH youth mental health conference (continued)
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 Drugs in focus – policy brieﬁ ng
Responding to new psychoactive substances
Cited from Drugs in focus, No. 22, 2nd issue 2011
Key issues at a glance
1. New psychoactive substances are not easily detected 
and identiﬁ ed by forensic laboratories. This may hinder 
targeted and timely responses by legislators and law 
enforcement.
2. It is not legally possible to criminalise the unauthorised 
distribution of all psychoactive substances, so legislation, 
rather than being proactive, can only react to substances 
as they appear.
3. New psychoactive substances may pose risks to 
individual and public health as well as social risks, 
affecting the broader community. However, when 
they ﬁ rst appear on the market, information on their 
associated risks is lacking.
4. The legislative procedure required to bring a substance 
under the control of the drug laws takes time, in some 
countries more than a year.
5. Controlling a new psychoactive substance might have 
unintended and unwanted consequences. It may 
stimulate the search for, and distribution of, a non-
controlled replacement, possibly one more harmful than 
its predecessor.
6. Other control options, though faster, lack the penalties 
to send the same messages of deterrence and health risk. 
Furthermore, they might not be effective in preventing 
or stopping the marketing and distribution of a new 
substance.
Conclusions and policy considerations
1. Detecting and identifying new psychoactive substances 
as they appear on the market are the ﬁ rst steps to 
assessing the risks of, and ultimately controlling, 
potentially dangerous new drugs. The capacity to 
achieve this task is an essential element of early-warning 
systems.
2. Risk assessment systems can provide evidence to support 
the legislative process. Targeted research is key to 
providing a ﬁ rm evidence base for risk assessment and 
for ongoing justiﬁ cation of control measures.
3. Striking the right balance between swiftness of response 
to new substances, on the one hand, and sufﬁ cient 
scientiﬁ c evidence and legislative supervision, on the 
other, is an important policy goal.
4. Drug laws should address substances that pose serious 
health and social threats. Other measures, combined 
with prevention programmes, may also be used to 
dissuade the use of non-controlled substances that are 
not necessarily safe.
5. It is important to consider if other laws already available, 
such as consumer protection and medicines laws, might 
achieve the desired objective. Speed of reaction may be 
more important than severity. Import bans can reduce 
pressure on local enforcement mechanisms.
6. The European Commission, in co-operation with EU 
countries, the EMCDDA and Europol, is working on 
new legislation to better address the control of new 
psychoactive substances throughout the EU.
From Drugnet Europe
Drugs and driving
Cited from article by Brendan Hughes in Drugnet Europe, No. 
76, October–December 2011
Many countries around the world are now developing 
solutions to deal effectively with the problem of drugs and 
driving. In July 2011, the Canadian Centre on Substance 
Abuse (CCSA) — in partnership with the EMCDDA, the 
United States Ofﬁ ce of National Drug Control Policy 
(ONDCP) and the US National Institute on Drug Abuse 
(NIDA) — hosted the ﬁ rst international symposium on the 
subject in Montreal, Canada.
 The purpose of the symposium was to build on the 
2011 resolution on drugged driving adopted by the 
UN Commission on Narcotic Drugs. This recognises the 
importance of a coordinated approach to addressing the 
health and public safety consequences of this practice, 
through evidence-based research. A ﬁ nal report on the 
symposium will be published on the CCSA website 
(www.ccsa.ca). 
In Europe, the complex issue of drugged driving has been 
the subject of the multi-country DRUID project (Driving 
under the inﬂ uence of drugs, alcohol and medicines), 
which held its ﬁ nal conference in September 2011. The 
EUR 24 million project, which has published over 30 
reports (‘see deliverables’) on its website, used harmonised 
data-collection protocols to examine the effects of these 
substances on road safety (www.druid-project.eu). 
Overdose deaths — just the tip of the iceberg?
Cited from Drugnet Europe, No. 76, October–December 2011
Over 7 600 fatal overdoses were reported in the EU and 
Norway in 2009, with opioids associated with the majority 
of these. But studies suggest that overdose deaths could be 
just the tip of the iceberg. A Selected issue publication on 
drug-related mortality published alongside the Annual report 
estimates that around 10 000 to 20 000 problem opioid users 
could be dying each year in Europe, mainly from overdose, 
but also from diseases, suicide and trauma. 
The review looks at the ‘excess mortality’ in regular opioid 
users (risk of death compared with the general population) 
and ﬁ nds that their risk of dying is 10 to 20 times higher than 
for their non-drug-using peers. The report underlines the role 
that services can play in reducing the human costs of long-
term drug problems. Under evaluation in some countries are 
programmes targeting periods known to be risky for opioid 
users (e.g. leaving prison, dropping out of treatment).
Drugnet Europe is the quarterly newsletter of the 
European Monitoring Centre for Drugs and Drug 
Addiction (EMCDDA). Drugs in focus is a series of policy 
brieﬁ ngs published by the EMCDDA. Both publications 
are available at www.emcdda.europa.eu.
If you would like a hard copy of the current or 
future issues of either publication, please contact: 
Health Research Board, Knockmaun House, 
42–47 Lower Mount Street, Dublin 2. 
Tel: 01 2345 148; Email: drugnet@hrb.ie
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 In brief
On 6 June 2011 the Pharmaceutical Society of Ireland 
presented the Minister for Health, Dr James Reilly TD, with 
the results of the ﬁ rst baseline research into community 
pharmacy practice in Ireland. A key element of the 
research was to examine the current service offering within 
pharmacies across the country, with a particular emphasis 
on the extent of the provision of ‘enhanced pharmacy 
services’, i.e. ‘services implemented in pharmacies that are 
additional to or not routinely provided with prescribed or 
non-prescribed medicines’. The following table outlines 
the responses with regard to two drug-related services. 
www.pharmaceuticalsociety.ie
Currently provided
Not currently provided, 
would like to provide in 
future
Not currently provided, 
would not like to provide 
in future
n % n % n %
Supervised methadone service 140 36.1 74 19.1 174 44.8
Needle exchange 10 2.7 128 35.1 227 62.2
Between 22 and 24 September 2011 the European Society 
for Social Drug Research held its 22nd annual conference 
in Aarhus, Denmark. The results of two Irish research projects 
were presented. (1) A longitudinal pathways analysis of 
drug use among homelessness young people (Paula Mayock 
and Mary Louise Corr). The presenters focused on the 
relationship between the homeless and drug pathways. 
They described a connection between downward transitions 
in drug consumption and positive housing experiences, 
on the one hand, and upward transitions in drug use and 
chronic housing instability, on the other. They argued for 
a conceptual shift towards a focus on housing, rather than 
homelessness, when attempting to explain change in the 
drug consumption patterns of young people who negotiate 
the experience and consequences of homelessness during 
the transition to adulthood. (2) A qualitative study, using 
grounded theory, of treatment-seeking among heroin users 
(Anne McDonnell and Marie van Hout). Describing the social 
and contextual factors which enable change in perception of 
heroin use, recovery and treatment, the study supports the 
view that the concept of ‘turning points’ in the life course 
are valuable when thinking about how people give up the 
use of drugs. www.essd-research.eu
In September 2011 Issue 67 of Working Notes, the journal 
of the Dublin-based Jesuit Centre for Faith and Justice, 
included an article by Fr Peter McVerry SJ, in which he calls 
for a radical appraisal of current approaches to dealing with 
illegal drug use. Pointing out that ‘drug policy’ encompasses 
both policies to deal with the supply of drugs and policies to 
deal with demand, he says that addressing supply absorbs 
by far the greater share of public expenditure. Yet, despite 
successes in intercepting supplies, the inﬂ ow of drugs 
continues, with powerful criminal gangs controlling this 
trade. He suggests that the ﬁ ndings and recommendations 
of the Global Commission on Drug Policy, published in 
June 2011, provide some useful guidelines for the much-
needed public and political debate on the issue.1 In relation 
to policies to control demand, Fr McVerry highlights the 
importance of addressing demand among those who are 
habitual users or who are addicted to drugs. He emphasises 
the need for a comprehensive range of detoxiﬁ cation, 
rehabilitative and after-care services, and says that it is 
essential that these be accessible without undue delays. 
While the importance of all these elements has long been 
recognised in ofﬁ cial policy and strategy statements, 
provision falls far short of need, and existing services are 
endangered by current cutbacks in public funding. 
www.workingnotes.ie 
In September 2011 the Council of Europe published 
Some still more equal than others? Or equal opportunities 
for all?. The author of the report described research 
showing that inequality – in opportunities, wealth or 
health – is widespread in Europe and that the citizens of 
richer countries do not necessarily have healthier proﬁ les 
than those of poorer countries; moreover, the citizens of 
egalitarian countries have the highest life expectancy. 
http://book.coe.int/EN 
On 1 November 2011 Merchants Quay Ireland opened 
its new fully medically supervised residential detox unit at 
St Francis Farm, Tullow, Co Carlow. For referrals and further 
information please contact Rose Sheppard, Clinical Nurse 
Manager, Sycamore House, St Francis Farm, Tullow, Co 
Carlow, Tel: 087–9603905, e-mail: rose.sheppard@mqi.ie 
On 18 November 2011 the annual reports for 2010 of 
the Prison Visiting Committees to Arbour Hill, Cloverhill, 
Castlerea, Cork, Dóchas Centre, Limerick, Loughan House, 
Midlands, Mountjoy, Portlaoise, Shelton Abbey, St Patrick’s 
Institution, the Training Unit and Wheatﬁ eld were launched. 
www.justice.ie 
On 30 November 2011 the Central Statistics Ofﬁ ce 
published the preliminary results of the 2010 Survey on 
Income and Living Conditions (SILC). Ireland’s ofﬁ cial source 
of data on household and individual income, including key 
national poverty indicators, SILC 2010 shows the following 
changes since the 2009 survey:
 ■ Average annual equivalised disposable income (i.e. 
household income adjusted for household composition) 
dropped by 5%, from €23,326 in 2009 to €22,168 in 
2010.
 ■ Income inequality increased, with the average income of 
those in the highest income quintile being 5.5 times that 
of those in the lowest income quintile, compared to 4.3 
one year earlier.
 ■ Although the at-risk-of-poverty threshold decreased by 
more than 10% in 2010, the at-risk-of-poverty rate rose 
by 1.7%, from 14.1% in 2009 to 15.8% in 2010.
 ■ The deprivation rate (those experiencing two of more 
types of enforced deprivation) rose by nearly 6%. This 
increase was largely attributable to an increase in the 
deprivation rate among those NOT at risk of poverty, 
from 13.7% in 2009 to 19.3% in 2010. www.cso.ie 
(Compiled by Brigid Pike)
1. See ‘In brief’ in Issues 37 and 39 of Drugnet Ireland for a 
short account of the work and ﬁ nal report of the Global 
Commission on Drug Policy. 
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 Recent publications
Journal articles
The following abstracts are cited from recently published articles 
relating to the drugs and alcohol situation in Ireland.
Brief interventions are effective in reducing alcohol consumption in 
opiate-dependent methadone-maintained patients: results from an 
implementation study
Darker C, Sweeney B, El Hassan HO, Smyth BP, Ivers, JH and Barry J 
Drug and Alcohol Review, 2011, September, Early online 
www.drugsandalcohol.ie/15943
This study aimed to test the feasibility and effectiveness of brief 
interventions (BIs) to reduce hazardous and harmful alcohol 
consumption in opiate-dependent methadone-maintained patients. 
Methods involved before and after intervention comparison of 
Alcohol Use Disorders Identiﬁ cation Test (AUDIT-C) scores from 
baseline to three-month follow up. Seven hundred and ten (82%) 
of the 863 eligible methadone-maintained patients within three 
urban addiction treatment clinics were screened. A WHO protocol 
for a clinician-delivered single BI to reduce alcohol consumption 
was delivered. One hundred and sixty (23% of overall sample 
screened) ‘AUDIT-positive’ cases were identiﬁ ed at baseline 
screening with a mean total full AUDIT score of 13.5 (SD 6.7). 
There was a statistically signiﬁ cant reduction in AUDIT-C scores 
from T1 to T2 for the BI group. There was a statistically signiﬁ cant 
decrease in the proportion of men who were AUDIT-positive 
from T1 to T2. The authors conclude that it is feasible for a range 
of clinicians to screen for problem alcohol use and deliver BI 
within community methadone clinics. Opiate-dependent patients 
signiﬁ cantly reduced their alcohol consumption as a result of 
receiving a BI. 
Does concurrent cocaine use compromise 1-year treatment 
outcomes for opiate users? 
Cox G and Comiskey C 
Substance Use and Misuse, 2011; 46(9): 1206–1216. 
www.drugsandalcohol.ie/14865
This study aimed to determine whether cocaine use compromises 
treatment outcomes for opiate users. Data were collected from 
404 opiate users at treatment intake and 1-year follow-up as 
part of a national treatment outcome study. Because of higher 
intake measures, cocaine users improved in more outcomes than 
nonusers, but comparisons between groups found that cocaine 
users had more coexisting problems. Regression analysis revealed 
that those who used cocaine at intake were more likely to use 
cocaine at 1-year follow-up, to commit crime, and to be homeless. 
It is concluded that treatment for opiate use ‘works’ even in the 
presence of concurrent cocaine use.
Users, carers and professionals experiences of treatment and care for 
heroin dependency: implications for practice. A preliminary study
Braden M, McGowan IW, McLaughlin DF, McKenna H, Keeney S 
and Quinn B 
Journal of Substance Use, 2011; 16(6): 452–463. 
www.drugsandalcohol.ie/16653
This paper reports on the treatment and care experiences for heroin 
dependency in a Northern Ireland healthcare trust. Focus groups 
were undertaken with separate purposive samples of ex//current 
heroin users ( n = 7), carers of ex//current heroin users ( n = 4) 
and professionals involved in heroin dependency service provision 
( n = 4). Non-directive question schedules elicited collective 
phenomenological experiences. Focus groups were transcribed 
verbatim and content analyzed. 
Findings: Study participants shared mainly dehumanizing 
experiences of treatment and care provision often characterized by 
non-communicative and judgemental health professional conduct. 
Unpredictable prescribing protocol and limited treatment resources 
overshadowed any beneﬁ cial experiences of substitute prescribing 
in our pilot study. Findings also showed that participants requested 
treatment choice and holistic care provision. Conclusions: 
Incoherent drug treatment policy and communication breakdown 
between treatment stakeholders has inﬂ uenced a cyclical blame 
culture in this study.
Area of residence and alcohol-related mortality risk: a ﬁ ve-year 
follow-up study
Connolly S, O’Reilly D, Rosato M and Cardwell C 
Addiction, 2011; 106(1): 84–92. 
www.drugsandalcohol.ie/14503
This was a ﬁ ve-year longitudinal study of individual and area 
characteristics of those dying and not dying from alcohol-related 
deaths.
Participants: A total of 720,627 people aged 25–74, enumerated 
in the Northern Ireland 2001 Census, not living in communal 
establishments.
Findings: There was an increased risk of alcohol-related mortality 
among disadvantaged individuals, and divorced, widowed 
and separated males. The risk of an alcohol-related death was 
signiﬁ cantly higher in deprived areas for both males [hazard ratio 
(HR) 3.70; 95% conﬁ dence interval (CI) 2.65, 5.18] and females 
(HR 2.67 (95% CI 1.72, 4.15); however, once adjustment was 
made for the characteristics of the individuals living within areas, 
the excess risk for more deprived areas disappeared. Both males 
and females in rural areas had a reduced risk of an alcohol-related 
death compared to their counterparts in urban areas; these 
differences remained after adjustment for the composition of the 
people within these areas. 
Conclusions: Alcohol-related mortality is higher in more deprived, 
compared to more afﬂ uent areas; however, this appears to be due 
to characteristics of individuals within deprived areas, rather than to 
some independent effect of area deprivation per se. Risk of alcohol-
related mortality is lower in rural than urban areas, but the cause is 
unknown.
Over-the-counter medicine abuse – a review of the literature
Cooper RJ 
Journal of Substance Use, 2011, 3 October; Early online 
www.drugsandalcohol.ie/16456
This review describes the current knowledge and understanding 
of OTC medicine abuse, as found in a comprehensive search 
of international empirical and review literature between 1990 
and 2011. Findings were: OTC medicine abuse was identiﬁ ed in 
many countries and although implicated products varied, ﬁ ve key 
groups emerged: codeine-based (especially compound analgesic) 
medicines, cough products (particularly dextromethorphan), 
sedative antihistamines, decongestants and laxatives. No clear 
patterns relating to those affected or their experiences were 
identiﬁ ed and they may represent a hard-to-reach group, which 
coupled with heterogeneous data, makes estimating the scale of 
abuse problematic. Associated harms included direct physiological 
or psychological harm (e.g. opiate addiction),harm from another 
ingredient (e.g. ibuprofen-related gastric bleeding) and associated 
social and economic problems. Strategies and interventions 
included limiting supplies, raising public and professional awareness 
and using existing services and internet support groups, although 
associated evaluations were lacking. Terminological variations were 
identiﬁ ed.
Conclusions: OTC medicine abuse is a recognised problem 
internationally but is currently incompletely understood. Research 
is needed to quantify scale of abuse, evaluate interventions and 
capture individual experiences, to inform policy, regulation and 
interventions
drugnet 
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 Upcoming events
(Compiled by Joan Moore – jmoore@hrb.ie)
February 
17 February 2012
CityWide call for drug alliance initiative, and launch of policy 
document and ﬁ lm 
Venue: Liberty Hall Theatre, Dublin 12:30pm
Organised by: CityWide Drugs Crisis Campaign
Email: info@citywide.ie
www.citywide.ie
Information: CityWide emerged from a mass meeting of 
community activists and local residents which took place in 
Liberty Hall in 1995. Seventeen years later we are inviting all 
those interested in ﬁ nding ways of collaborating to respond to 
the devastating impact of the continuing drugs crisis. We believe 
it's time to build a broad alliance campaign to put the drugs crisis 
in our communities back on the political agenda. The event will 
bring together people working in community projects, community 
representatives, trade unions, academics, faith communities, public 
representatives and community networks.
The CityWide ﬁ lm will have its ﬁ rst showing at this event. Filmed 
during 2010, this project set out to show how drugs have impacted 
on communities, how those communities have responded, how 
national drugs strategies developed and how CityWide has worked 
locally and nationally.
The CityWide 4th policy document will be launched. Based on 
wide consultation with community representatives and projects, 
drugs task forces and others, our new policy document highlights 
the continuing drugs crisis, it explains its complexity and impacts 
and it makes practical proposals.
March, May and June
Managing the Performance, Safety and Health Risks of Employee 
Drug and Alcohol Use
Venues: Various
Organised by / Contact: EAP Institute
Email: anita@eapinstitute.com
www.eapinstitute.com
Tel: +353 (0)51 855 733
Thursday 1 March 2012
Cork, Rochestown Park Hotel
Thursday 17 May 2012
Galway, Carlton Hotel
Thursday 14 June 2012
Portlaoise, Heritage Hotel
Information: An information sheet on intoxicants at work posted on 
the Health & Safety Authority (HSA) website on 20 September 2011 
conﬁ rmed that the HSA will not be issuing any codes of practice or 
regulations on intoxicant testing. Where testing is part of company 
policy or forms part of employee contracts, it is recommended that 
the testing should be carried out in accordance with a recognised 
standard such as the European Workplace Drug Testing Society 
(EWDTS) Guidelines for legally defensible drug testing. 
The purpose of this seminar is to outline an approach that 
companies can implement, in managing the performance, safety 
and health 
risks of employee drug and alcohol abuse. Seminar speakers and 
topics will include: 
Maurice Quinlan – Guidance on Developing a Comprehensive 
Approach to Workplace Intoxicants (deﬁ ned as drugs and 
alcohol); 
Michael Magennis – European Workplace Drug Testing Society 
(EWDTS) Guidelines on Legally Defensible Workplace Drug 
Testing.
May 
30–31 May 2012
Sixth Annual Conference of the International Society for the Study 
of Drug Policy 
Venue: Cathedral Lodge, Canterbury
Organised by / Contact: ISSDP
www.issdp.org/conferences.php
Information: This event will be hosted by the University of Kent 
(School of Social Policy, Sociology and Social Research). The call for 
abstracts is now open. For details, please see ISSDP website. The 
invited keynote speakers are:
Professor Thomas McLellan, University of Pennsylvania 
(formerly Deputy Director of the US Ofﬁ ce for National 
Drug Control Policy) 
Dr Michel Kazatchkine, Executive Director of the Global 
Fund and member of the Global Commission on Drug 
Policy. 
Dr Fiona Measham, University of Lancaster and member of 
the UK Advisory Council on the Misuse of Drugs 
Martin Jelsma, Transnational Institute 
The conference will discuss a wide range of drug policy issues, with 
a particular focus on ‘how can and do empirical studies inﬂ uence 
drug policy?
July 
2–13 July 2012
ISCTE–EMCDDA summer school on illicit drugs
Venue: Lisbon
Organised by / Contact: 
Email: drugsummerschool.cies@iscte.pt
www.drugsummerschool.cies.iscte-iul.pt/np4/home
Information: The Lisbon-based Instituto Superior das Ciências do 
Trabalho e da Empresa (ISCTE) and the EU drugs agency (EMCDDA) 
are currently collaborating on a summer school programme ent 
itled: ‘Illicit drugs in Europe: supply, demand and public policies’. 
During the two-week course, EMCDDA scientiﬁ c experts, ISCTE-
professors and policymakers, will prepare participants to meet 
the complex policy challenges in this ﬁ eld, by providing a multi-
disciplinary and inclusive approach to the study of the drug 
problem, both in Europe and beyond. The target audiences for 
the summer school are university students (undergraduate and 
graduate), researchers, professionals and administrators interested 
or working in the drugs ﬁ eld. ECTS credits will be given for the 
courses and students can transfer credits to other European 
universities using the ECTS-system
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